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Abstract  
 
Until recently, lysosomes were considered as the end-point of the endocytic pathway, to where 
cargo is delivered to be degraded. However, several studies showed that conventional lysosomes can 
undergo regulated exocytosis in response to an increase in intracellular calcium concentration, an 
important process for plasma membrane repair and secretion of lysosomal contents. Nevertheless, the 
molecular machinery involved in lysosome transport and fusion with the plasma membrane is not fully 
understood. Our group found recently that the small GTPases Rab11a and Rab11b are essential for 
calcium-triggered lysosome exocytosis in HeLa cells.  
Therefore, we aim to find the Rab11a/b effectors that mediate lysosome exocytosis process. To 
this end, we silenced several known effectors such as Rab11 family of interacting proteins (FIPs), 
Myosin Va/b or subunits of the exocyst tethering complex (Sec8, Sec15 and Exo70). After stimulation 
with the calcium ionophore ionomycin, we investigated the cell surface expression levels of the late 
endosome/lysosome marker LAMP1, as well as the release of the lysosomal enzyme β-
hexosaminidase. We found that the silencing of Sec15 impairs lysosome exocytosis, while in the 
absence of FIP1-C or FIP2 there is an increase in LAMP1 cell surface levels and β-hexosaminidase 
release. Moreover, we confirmed the interaction and co-localization of Rab11a/b with the effector 
proteins studied using co-immunoprecipitation assays and confocal immunofluorescence microscopy, 
respectively. Finally, using live cell imaging, we found that Rab11-positive vesicles interact transiently 
with late endosomes/lysosomes near the plasma membrane, upon ionomycin stimulation.  
Thus, our results provide new insights into the role of Rab11 and its effectors in the regulation of 
conventional lysosome exocytosis. 
 
Keywords: Lysosome, exocytosis, Rab11, effector 
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Resumo 
 
Até há pouco tempo os lisossomas eram apenas conhecidos como organelos degradativos, para 
onde convergem moléculas para serem degradadas. No entanto, vários estudos mostraram que os 
lisossomas convencionais também podem ser exocitados de uma forma regulada, em resposta ao 
aumento da concentração intracelular de cálcio, um evento importante para a reparação da membrana 
plasmática e secreção do conteúdo lisossomal. Porém, a maquinaria molecular envolvida no transporte 
e fusão dos lisossomas com a membrana plasmáticas ainda não é bem conhecida. O nosso grupo 
descobriu que as pequenas GTPases Rab11a e Rab11b são essenciais na exocitose de lisossomas 
induzida por cálcio, em células HeLa. 
Por este motivo, o nosso objetivo é encontrar efetores das Rab11a/b que medeiam a exocitose de 
lisossomas. Para isso, silenciámos vários efetores conhecidos como a família de proteínas que 
interagem com a Rab11 (FIPs), Miosina Va/b ou subunidades do complexo exocisto (Sec8, Sec15 e 
Exo70). Após estimulação com o ionóforo de cálcio ionomicina, investigámos os níveis de expressão 
do marcador de endossomas tardios/lisossomas LAMP1 à superfície da célula, bem como a libertação 
da enzima lisossomal β-hexosaminidase. Verificámos que o silenciamento da subunidade Sec15 
diminui a exocitose de lisossomas, e que a ausência de FIP1-C ou FIP2 leva ao aumento dos níveis de 
expressão de LAMP1 à superfície da célula e da libertação de β-hexosaminidase. Além disso, 
confirmámos a interação e co-localização das Rab11a/b com as proteínas efetoras estudadas, usando 
ensaios de co-imunoprecipitação e microscopia confocal de imunofluorescência, respetivamente. 
Finalmente, usando microscopia em células vivas, verificámos que vesículas Rab11 positivas 
interagem transientemente com endossomas tardios/lisossomas perto da membrana plasmática, após 
estimulação com ionomicina. 
Desta forma, os nossos resultados providenciam novos dados sobre o papel da Rab11 e dos seus 
efetores na regulação da exocitose de lisossomas convencionais. 
 
Palavras chave: Lisossomas, exocitose, Rab11, efetor 
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I. Introduction 
 
1. Vesicular trafficking 
 
The evolution of eukaryotic cells led to an increase in intracellular complexity, particularly in the 
compartmentalization of biological functions into organelles and the need of communication between 
them in a specific and regulated manner. Such communication is achieved through vesicular transport 
pathways, between donor and acceptor compartments, which involves four distinct steps.  
The first step is the budding of a vesicle with specific cargo from a donor compartment (Figure I.1, 
step 1). This process is facilitated by coat proteins that are recruited from the cytosol to the budding site. 
Moreover, coat proteins bind to adaptor proteins that assist in cargo selection by recognizing sorting 
signals present in the cytosolic domains of transmembrane proteins (Bonifacino and Lippincott-
Schwartz, 2003). Clathrin-coated vesicles, composed of the coat clathrin, were the first to be described 
and are responsible for the uptake of extracellular molecules, as well as the transport from the trans-
Golgi network (TGN) to endosomes (Bonifacino and Lippincott-Schwartz, 2003; Cai et al., 2007). 
However, there are other types of coated vesicles, like COP I/II-coated vesicles, which are involved in 
trafficking between the endoplasmic reticulum (ER) and the Golgi complex (Bonifacino and Lippincott-
Schwartz, 2003; Cai et al., 2007). In the following step, vesicles are uncoated and transported to the 
acceptor compartment via the actin and microtubule cytoskeletons (Figure I.1, step 2). This transport is 
ensured by actin-dependent motor proteins, such as Myosins (Hartman and Spudich, 2012), as well as 
kinesins and dyneins, which transport vesicles along microtubules (Cooper, 2000). While kinesins direct 
vesicular transport towards the cell periphery, dyneins transport cargo from periphery to the cell center 
(Cooper, 2000). Finally, the tethering and fusion of vesicles to specific acceptor compartments are 
mediated by tethers, such as the exocyst (Figure I.1, step 3), and the soluble N-ethylmaleimide-
sensitive-factor attachment protein receptors (SNAREs), respectively. SNAREs are present both in 
vesicles (v-SNAREs) and target membranes (t-SNAREs), allowing the fusion of vesicles to specific 
acceptor compartments and the release of cargo (Figure I.1, step 4) (Hong and Lev, 2014). Additionally, 
there are other regulatory components that modulate the action of SNAREs, namely Synaptotagmins 
and Ras small GTPases.  
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In eukaryotic cells, there are two main pathways of vesicular trafficking, namely the endocytic and 
the exocytic/secretory pathways (Figure I.2). In the endocytic pathway, cargo is internalized via clathrin-
dependent or independent mechanisms and delivered to early/sorting endosomes (EE/SE). These 
mature and can direct cargo to different routes. Cargo can be directed to late endosomes (LE) and 
lysosomes for degradation. Moreover, cargo can follow a fast recycling pathway from EE to the plasma 
membrane (PM) or a slow recycling pathway through the endocytic recycling compartment (ERC), 
located in the perinuclear region (Ijzendoorn 2006; Si et al., 2009). The secretory pathway is followed 
by newly synthesized cargo, which is transported from the ER to the Golgi apparatus and from there to 
endosomes to the PM. Exocytosis is the final step of the secretory pathway, which refers to the vesicle 
fusion with the PM, allowing the release of their contents to the extracellular space. Exocytosis can be 
constitutive or regulated. Constitutive exocytosis is the result of a steady-state trafficking of secretory 
vesicles from the ER to the PM.  In the case of regulated exocytosis, an external stimulus is required to 
induce exocytosis. For example, the increase in intracellular calcium (Ca2+) concentration is known to 
trigger exocytic events in specialized secretory cells, such as endocrine and neuronal cells (Shandala 
et al., 2012).  
Figure I.1 - Vesicular trafficking steps. 1- Budding of a vesicle from the donor compartment; 2- Transport along 
the cytoskeleton; 3-Tethering and docking to the target compartment; 4- Fusion and release of vesicle content. 
Taken from Prekeris, 2003. 
 
Figure I.2 - Vesicular trafficking steps. 1- Budding of a vesicl  from the donor compartment; 2- Transport alo g 
cytoskeleton; 3-Tethering and docking to the target compartment; 4- Fusion and release of vesicle content. Taken 
from Prekeris, 2003. 
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All steps of membrane trafficking need to be tightly regulated to ensure the correct communication 
between organelles. Several groups of molecules confer spatial and temporal regulation to all 
membrane trafficking steps. Prominent among them are the Rab small GTPases (Prekeris, 2003; Li et 
al., 2013). 
 
 
 Rab GTPase family 
 
 
Rab small GTPases are master regulators of all steps of vesicular transport, maintaining 
compartment identity and controlling endocytic and exocyitc pathways (Figure I.3) (Schwartz et al., 
2008). These are small proteins with 20-30 kDa that in most cases belong to the Ras superfamily, which 
is composed of five main families: Rat sarcoma (Ras), Ras homologous (Rho), ADP-ribosylation factor 
(Arf), Ras-like nuclear (Ran) and Ras-like in brain (Rab) (Bhuin and Roy, 2014; Reiner and Lundquist, 
2016). 
Rab GTPases are evolutionary conserved and ubiquitously expressed in all eukaryotic cells. 
However, there are some Rabs that are expressed only in certain tissues or have cell-type specific 
functions (Stenmark and Olkkonen, 2001; Stenmark, 2009). To date, around 65 Rabs were identified in 
humans. Rab proteins have similar structures and highly conserved regions, including a nucleotide 
binding domain, that can bind to guanosine triphosphate (GTP) or guanosine diphosphate (GDP). When 
they are bound to GTP they are considered active and when they are bound to GDP they are inactive. 
Figure I.2 - Intracellular trafficking pathways. Endocytic pathway (blue arrows): Cargo is internalized and 
delivered to lysosomes through early/sorting endosomes and late endosomes. Recycling pathway (green arrows): 
Cargo can be recycled back to the plasma membrane through the endocytic recycling compartment (slow recycling) 
or directly from sorting endosomes (fast recycling). Exocytic pathway (red arrows): Vesicular transport of newly 
synthesized cargo from endplasmic reticulum to PM,  through the Golgi apparatus. Adapted from Seixas et al., 
2013. 
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However, Rab proteins are also composed by a variable region, localized at the carboxyl (C)-terminal, 
which has been implicated in targeting to specific subcellular locations (Stenmark and Olkkonen, 2001; 
Mitra et al., 2011). Based on specific sequence motifs, Rab GTPases can be divided into several 
subfamilies, such as, Rab1, Rab3, Rab5, Rab6, Rab8, Rab11, Rab22, Rab27 and Rab40. However, 
there are some Rab small GTPases that lack a subfamily-specific motif and cannot be grouped into 
subfamilies, namely Rab20, Rab17, Rab41 and Rab33 (Pereira-Leal and Seabra, 2000; Stenmark and 
Olkkonen, 2001). Moreover, several Rab proteins, like Rab11 (Junutula et al., 2004) and Rab27 (Barral 
et al., 2002), have different isoforms that can perform partially redundant functions.  
The subcellular localization of each Rab protein is directly related to its function (Figure I.3). For 
instance, Rab1 and Rab2 are located at the ER and Golgi apparatus, respectively, regulating ER-to-
Golgi trafficking (Stenmark, 2009; Bhuin and Roy, 2014). Rab6 and Rab8 are located at the Golgi 
apparatus and regulate the transport of newly synthesized membrane proteins from the TGN to the PM 
(Stenmark, 2009; Bhuin and Roy, 2014). Rab3, Rab27 and Rab37, localize to secretory vesicles, and 
are involved in several regulated secretory events (Stenmark, 2009). Rab22 is located in vesicles 
involved in trafficking between the TGN and EEs. Rab5 localizes to EEs and regulates EE homotypic 
fusion. Rab11 localizes to the ERC and regulates slow recycling, while Rab4 localizes to sorting 
endosomes and is involved in the fast recycling pathway (Stenmark, 2009; Bhuin and Roy, 2014). Rab7 
localizes to LEs and regulates their maturation and the interaction with lysosomes. Rab9 is also 
important for LE function, since it regulates the trafficking between the TGN and LEs (Stenmark, 2009). 
Moreover, it has been reported that different Rab proteins can localize in the same organelle, defining 
distinct microdomains and increasing the complexity of their regulatory functions (Stenmark and 
Olkkonen, 2001). For example, endosomes can be simultaneously positive for Rab5, Rab4 and Rab11, 
which create different microdomains, and lead to the sorting of cargo into different pathways. LEs can 
also be enriched in both Rab7 and Rab9 defining different steps of late endosome maturation (Stenmark, 
2009; Pfeffer, 2013).  
 
 
 
 
 
 
 
 
 
Figure I.3 - Localization and function of Rab GTPases.  Rab proteins are localized to all intracellular membranes, 
playing several roles in all vesicular trafficking pathways. Taken from Stenmark, 2009. 
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Rab proteins function as molecular switches, cycling between a GTP-bound and GDP-bound state 
(Figure I.4) (Schwartz et al., 2008). Depending on the nucleotide bound, GTPases adopt different 
conformations in mainly two regions called “switch I” and “switch II”, which are localized at the N-
terminal. Moreover, the different conformations determine the interaction of the Rabs with regulatory 
proteins (Wennerberg et al., 2005; Stenmark, 2009). The cycling of GTPases is regulated by guanine-
nucleotide-exchange factors (GEFs) and GTPase-activating proteins (GAPs). GEFs catalyze the 
exchange of GDP by GTP, activating Rabs, while GAPs catalyze the intrinsic guanosine triphosphatase 
(GTPase) activity of Rabs, which leads to the hydrolysis of GTP, and the inactivation of the proteins 
(Park, 2013; Pfeffer, 2013). The regulation of the nucleotide binding state of Rabs is intrinsically coupled 
to their reversible association with membranes. Newly synthesized Rabs are inactive and have low 
affinity to membranes. To allow their association with membranes, Rab-escort protein (REP) binds to 
newly synthesized Rabs and recruits Rab geranylgeranyltransferase (RabGGTase). This enzyme 
catalyzes a post-translational modification known as prenylation, adding hydrophobic geranylgeranyl 
groups to the C-terminal of Rab proteins. Rabs are then anchored to membranes  and activated by 
GEFs, which allow them to recruit specific effectors to perform their downstream functions (Mitra et al., 
2011). After exerting their function Rabs, are inactivated by GAPs and then recognized by guanine-
nucleotide dissociation inhibitors (GDI), which are responsible for membrane extraction and stabilization 
of Rab proteins in their inactive state.  Before inactive Rabs can be presented again to membranes, they 
need to be dissociated from GDI, in a step mediated by GDI displacement factors (GDF) (Schwartz et 
al., 2008; Mitra et al., 2011; Seixas et al,. 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
Figura I.4 - Rab GTPases cycle. Rab small GTPases interconvert cyclically between an active GTP-bound and 
an inactive GDP-bound state. Several regulators are involved in both activation/inactivation and 
association/dissociation with membranes Taken from Brighouse et al., 2010. 
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Rab small GTPases perform their functions through the direct or indirect interaction with effector 
proteins. They are able to regulate recruitment and function of coat, motor and tethering proteins and 
also other molecules involved in vesicular trafficking (Pfeffer, 2013), allowing the control of many 
molecular events at a restricted localization.  
 
 
1.1.1. Rab11 subfamily  
 
The Rab11 subfamily of Rab GTPases is evolutionary conserved and comprise three members 
(isoforms): Rab11a, Rab11b and Rab11c, also known as Rab25. Rab11a and Rab11b are closely 
related proteins sharing 90% amino acid identity, while only 60% of homology was found between 
Rab11a/b and Rab25 (Khvotchev et al., 2003; Kelly et al., 2012). In mammalians, Rab11 tissue 
expression is variable, according to the isoform. Rab11a is the best characterized and is ubiquitously 
expressed, whereas Rab11b is restricted to the brain, testis and heart. Rab25 is mostly expressed in 
epithelial tissues (Welz et al., 2014) and has been associated with cancer. Indeed, Rab25 was found to 
be overexpressed in several cancers, such as breast and ovarian, acting as a tumor promotor (Kelly et 
al., 2012), but was also identified as a tumor suppressor in other cancers, like colon carcinoma (Welz 
et al., 2014). 
Rab11 proteins are key regulators of specific intracellular trafficking steps. Rab11 proteins localize 
primarily to the ERC in the perinuclear region and in recycling endosomes (RE) in the cytoplasm (Welz 
et al., 2014). Rab11 is also found in the TGN and post Golgi-vesicles (Kelly et al., 2012; Welz et al., 
2014). The major role of Rab11 GTPase is the coordination of the slow endocytic recycling pathway 
(Ullrich et al., 1996), from the ERC to the PM (Figure I.5) (Welz et al., 2014). In fact, the recycling of 
several PM receptors, such as the transferrin receptor (TfR) (Ren et al., 1998), β2-adrenergic receptors 
(Moore et al., 2004), cannabinoid receptor 2 (Grimsey et al., 2011) or fibroblast growth factor receptor 
4 (Haugsten et al., 2014) are regulated by Rab11 GTPases. Rab11 is also involved in the regulation of 
several exocytic processes at the TGN, like the budding of a subset of TGN vesicles (Figure I.5) (Urbé 
et al., 1993) (Chen et al., 1998). Additionally, Rab11 plays other relevant cellular functions, such as the 
delivery of cargo to the cleavage furrow/midbody during cytokinesis, as well as cell migration, 
ciliogenesis, neuritogenesis and oogenesis (Figure I.5) (Welz et al., 2014). In recent years, Rab11 was 
also shown to be associated with constitutive and regulated exocytosis in specialized cells, such as 
neurons (Khvotchev et al., 2003), skin melanocytes (Tarafder et al., 2014) and cytotoxic T-lymphocytes 
(CTL) (Sluijs et al., 2013). 
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Similar to other small GTPases, Rab11 switches between an active GTP-bound and an inactive 
GDP-bound form, through the action of specific GAPs and GEFs. To date, three Rab11 GAPs 
(TBC1D11, TBC1D15 and Evi5) and one Rab11 GEF (Crag) (Welz et al., 2014) were described. In its 
active form, Rab11 is able to recruit specific effector proteins in order to fulfill its functions. Several 
Rab11 effector proteins were already identified, namely Rab11-family of interacting proteins (FIPs) 
(Horgan and McCaffrey, 2009), Rabphilin-11/Rab11BP (Mammoto et al., 2000), motor proteins such as 
Myosin Va and Myosin Vb (Lapierre et al., 2001; Lindsay et al., 2013), phosphoinositide 4-kinase β 
(Graaf et al., 2004), the Rab8-GEF, Rabin8 (Knodler et al, 2010)  and the exocyst complex subunit 
Sec15 (Zhang et al., 2004). Rab11 can interact with multiple effector proteins at the same time (Vetter 
et al., 2015) or it can share effectors with other Rab GTPases to coordinate specific intracellular 
pathways. 
 
 
1.1.2. Rab11 effectors 
 
1.1.2.1. Rab11 family of interacting proteins (FIPs) 
 
 
Among the Rab11 effector proteins identified so far, the Rab11-family of interacting proteins (FIPs) 
are the best characterized. FIPs are encoded by five genes (FIP1, FIP2, FIP3, FIP4 and FIP5). 
Alternative splicing was also reported, originating different isoforms for each FIP, like, FIP1-A, FIP1-B 
and FIP1-C. They are an evolutionarily conserved family, ubiquitously expressed and known to interact 
Figure I.5 - Rab11-regulated vesicle transport processes. The major function of Rab11 proteins is the 
coordination of the endocytic recycling pathway. Rab11 GTPases were found to have an important role in several 
cell functions, namely ciliogenesis, cytokinesis, neuritogenesis and oogeneis.Taken from Welz et al., 2014. 
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with different Rabs and Arfs.  The interaction of FIPs with Rab proteins, namely with Rab11, is mediated 
by a twenty amino acid C-terminal conserved domain called Rab-binding domain (RBD) (Horgan and 
McCaffrey, 2009; Kelly et al., 2012). FIPs are divided into two classes (Horgan and McCaffrey, 2009): 
Class I, which includes FIP1C (Rab-coupling protein (RCP)), FIP2 and FIP5 or Rip11/pp75/Gaf1 and 
class II, composed by FIP3 or Eferin/Arfophilin-1 and FIP4 or Arfophilin-2.  
Class I FIPs (FIP1/RCP, FIP2 and FIP5) contain a Ca2+-binding C2 domain near the N-terminal 
(Figure I.6), which interacts with phospholipids and targets Rab11-FIP complexes to endomembranes 
(Prekeris, 2003; Horgan and McCaffrey, 2009). FIP1/RCP is the most studied FIP1 transcript, and it was 
first described to interact with Rab11 and Rab14 in yeast (Prekeris, 2003). Rab11-FIP1 interaction is 
known to play a key role in endocytic sorting, trafficking of receptors, transport between ERC and TGN 
and also in recycling of PM receptors (Horgan and McCaffrey, 2009; Baetz et al., 2013). FIP2 has been 
associated with endosomal recycling processes (Kelly et al., 2012), where it functions as an adaptor 
protein between Rab11 and the motor protein Myosin Vb. The Rab11-FIP2-Myosin Vb complex is 
involved in the recycling of several receptors, channels and transporter proteins, thus regulating vesicle 
motility towards the cell periphery (Kelly et al., 2012; Baetz et al., 2013). FIP5 co-localizes with Rab11 
at RE, and is known to regulate protein recycling to the PM (Schonteich et al,  2008; Jing and Prekeris, 
2009). FIP5 was also found to regulate insulin granule exocytosis (Sugawara et al., 2009).  
Class II FIPs (FIP3 and FIP4) contain two EF-hands and a proline-rich region at the N-terminal 
(Figure I.6), which function as Ca2+-binding domains (Prekeris, 2003). Besides interacting with Rab11, 
FIP3 and FIP4 can also interact with Arf proteins, namely Arf5 and Arf6 (Prekeris, 2003). Both class II 
FIPs localize to the cleavage furrow/midbody during cell division (Horgan and McCaffrey,  2009; Baetz 
et al., 2013), and are involved in the delivery of membranes to this location, which requires the 
integration of signals both from Rab and Arf regulated pathways (Prekeris, 2003; Horgan and McCaffrey, 
2009). FIP3 plays a role in the late stages of cytokinesis, namely in abscission, while FIP4 was described 
to be important in the targeting of molecules to the cleavage furrow (Kelly et al., 2012).  
   
 
 
 
 
 
 
 
 
Figure I.6 – Structure of Rab11-family of interacting proteins. Class I FIPs share a Ca2+-binding C2-domain 
near the N-terminal, while class II FIPs contain two EF-hands and a proline-rich regions at the N-terminal.Taken 
from Horgan and McCaffrey, 2009 
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The formation of Rab11-FIP protein complexes defines discrete membrane subdomains, that 
regulate several vesicular trafficking steps  (Prekeris, 2003; Baetz et al., 2013). Furthermore, the 
interaction of Rab11 with FIPs and other molecules, such as motor proteins, seems to be important to 
ensure the correct subcellular localization of Rab11 proteins (Prekeris, 2003). 
 
 
1.1.2.2. Class V Myosins   
 
The subfamily of Class V unconventional Myosins is composed by Myosin Va (Myo Va), Myosin Vb 
(Myo Vb) and Myosin Vc (Myo Vc), each of them displaying different tissue distribution and regulating 
specific membrane traffic events (Trybus, 2008). Class V Myosins are responsible for cargo transport 
along the actin cytoskeleton (Trybus, 2008) and are known to interact direct and indirectly with small 
GTPases, controlling their localization and recruitment to specific membranes (Lapierre et al., 2001; 
Lindsay et al., 2013). Myo Va is expressed mainly in the brain and melanocytes, where the complex 
Myo Va-Melanophilin-Rab27a was shown to control melanosome tethering at the cell periphery (Strom 
et al., 2002). Myo Vb is primarily expressed in epithelial cells, where it has been linked to RE movement 
and recycling of PM receptors, in complex with Rab11 and FIP2 (Hales et al., 2002; Schafer et al., 2013). 
In non-polarized cells, recycling of PM receptors is also regulated by Myo Vb, which mediates Rab11a-
positive RE movement to the cell periphery (Lapierre et al., 2001). Rab11a-Myo Vb interaction, together 
with Rab8a, was also described to be involved in promoting regulated exocytosis in bladder umbrella 
cells (Khandelwal et al., 2013). Myo Vc is known to be involved in secretory granule trafficking (Jacobs 
et al., 2009) and interacts with Rab32 and Rab38 during the biogenesis and secretion of melanosomes 
(Bultema et al., 2014).  
 
 
1.1.2.3. Exocyst complex 
 
The evolutionarily conserved octameric protein complex, known as exocyst is composed of eight 
subunits: Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and Exo84 (Figure I.7) (T.Shandala et al., 
2012;  B. Wu and Guo, 2015).  In Drosophila melanogaster, the exocyst was described as an effector 
of different Rab GTPases, namely Rab3, Rab8, Rab11 and Rab27 (Wu et al., 2005). Although the 
complex is known to function only when all subunits are present, some reports suggest the existence of 
sub-complexes, namely Sec5-Exo84 and Sec10-Sec15, with unknown functions (Zhang et al., 2004; 
Heider and Munson, 2012).  
The exocyst complex is known to be recruited to sites with active exocytosis to regulate SNARE 
function and the tethering of secretory vesicles (Wu and Guo, 2015). Moreover, this protein complex 
was shown to be important in several other cellular functions, besides its function as vesicle tethers 
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(Heider and Munson, 2012; B. Wu and Guo, 2015). For example, the exocyst is necessary to ensure 
the correct localization of membrane-bound vesicles to specific target sites at the appropriate moment, 
for example during cytokinesis (Heider and Munson, 2012). Moreover, studies in yeast reported an 
interaction between the exocyst and the actin cytoskeleton, suggesting a role for the exocyst complex 
in vesicular transport (Heider and Munson, 2012). 
 
 
 
 
 
 
 
 
 
 
In mammalian cells, Sec15 was shown to interact directly with Rab11 in a GTP-dependent manner 
and to co-localize with Rab11 to the perinuclear region (Zhang et al., 2004). Rab11-Sec15 interaction 
might be important for endocytic recycling, directing recycling vesicles to the PM (Heider and Munson, 
2012; B. Wu and Guo, 2015). While Sec15 regulates the vesicular transport to the cell periphery, other 
subunits like Sec3 and Exo70 regulate the assembly of the complex at the PM (T.Shandala et al., 2012). 
In fact, it was shown that Rab11 and the exocyst complex participate in the exocytosis of recycling 
vesicles at the PM (Takahashi et al., 2012).  
The interaction of Rab11 with different effector proteins, can explain the specific functions of Rab11 
in different intracellular traffic pathways and the pleiotropic functions of this subfamily of Rab proteins.  
 
 
 
 
 
  
Figure I.7 - Rab11 interaction with the exocyst complex. -  Direct binding of Sec15 to Rab11 promotes vesicular 
transport to the cell periphery, leading to the assembly of the exocyst complex and tethering of vesicle to the PM. 
Taken from Welz et al., 2014. 
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2. Lysosomes 
 
Intracellular homeostasis is achieved by balancing what is endocytosed and exocytosed, as well as 
through what is newly-synthesized and degraded. In cells, lysosomes are the major organelles 
responsible for the degradation of several biomolecules, such as proteins, lipids and nucleic acids; 
(Mullins and Bonifacino 2001; Samie and Xu, 2014). Lysosomes are described as dense, acidic 
membrane-bound compartments, delimited by a single membrane. They accumulate in the perinuclear 
region of the cell but are also found dispersed in the cytoplasm and near the PM.  
Lysosomes are composed by a specific set of hydrolases that include sulphatases, phosphatases, 
lipases, proteases, carbohydrases and glycosidases (Mullins and Bonifacino, 2001; Samie and Xu, 
2014). The majority of the lysosomal enzymes requires an acidic luminal pH (pH 4.6-5) to be active. 
This pH is established and maintained by a proton pump, known as vacuolar-ATPase (v-ATPase), 
located in the lysosomal membrane (Samie and Xu, 2014). Lysosomes also contain several highly 
glycosylated proteins known as lysosome-associated membrane proteins (LAMP) 1, 2 and 3, lysosomal 
integral membrane protein (LIMP), which have important roles in lysosomal function, by mediating the 
interaction with other organelles (Luzio et al., 2000; Mullins and Bonifacino, 2001; Eskelinen, 2006). 
These proteins are commonly used as lysosomal markers, since they are major components of 
lysosomal membrane.  
Material destined for degradation is delivered to lysosomes via the endocytic/phagocytic and 
autophagic pathways (Li et al., 2013). Endocytosis starts with the uptake of PM receptors or extracellular 
soluble cargo into endocytic vesicles. These vesicles undergo maturation into EEs/SEs and through 
sorting processes cargo can be delivered to LEs (Li et al., 2013), which eventually fuse with lysosomes 
(Luzio et al., 2000;  Luzio et al., 2007), in a process mediated by the small GTPase Rab7 (Bucci et al., 
2000; Hyttinen et al., 2013). In parallel with the endocytic pathway, the autophagic pathway also delivers 
cytoplasmic components, such as misfolded proteins and dysfunctional organelles for turnover in the 
lysosomes (Hyttinen et al., 2013).  
Some cells contain specialized lysosomes, known as lysosome-related organelles (LROs), which 
share common features with lysosomes, including the biogenesis pathway, low pH, and the presence 
of hydrolytic enzymes and highly glycosylated membrane proteins (Mullins and Bonifacino, 2001; Luzio 
et al., 2014). However, LROs differ from conventional lysosomes in morphology, including in size, and 
in their biochemical composition (Blott and Griffiths, 2002; Sluijs et al., 2013), thus reflecting their 
divergent functions. While the major function of conventional lysosomes is the degradation of 
biomolecules, LROs have specific functions depending on the cell type. LROs can also undergo 
regulated exocytosis in response to stimuli, and hence they are also known as secretory lysosomes 
(Blott and Griffiths, 2002).  
LROs are present in different cell types, including the hematopoietic cell lineages (Raposo et al., 
2002). Platelets have dense granules and α-granules that are responsible for the secretion of molecules 
essential for blood clotting. Natural killer cells and cytotoxic T-lymphocytes have lytic granules that play 
a key role in the elimination of infected cells. Antigen-presenting cells, like dendritic cells, contain major 
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histocompatibility complex (MHC) class II compartments, where antigens are processed. Inflammatory 
mediators are stored in basophilic granules present in basophils and mast cells, while the defense 
against parasites and bacteria is mediated by specific granules in eosinophils and azurophilic granules 
in neutrophils (Raposo et al., 2002;  Seixas et al., 2013). 
However, LROs are also found in other cell types, for example in osteoclasts, they are responsible 
for bone resorption and remodeling (Raposo et al., 2002). In melanocytes, retinal and iris pigmented 
epithelial cells, melanosomes, are the LROs responsible for synthesis and storage of the pigment 
melanin (Wasmeier et al., 2008). Lung epithelial type II cells contain lamellar bodies, that store 
surfactants, which are required to avoid alveolar collapse. Finally endothelial cells secrete hemostatic 
and proinflammatory factors that are stored in Weibel-Palade bodies (Raposo et al., 2002; Seixas et al., 
2013).  
 
 
 Regulated exocytosis of conventional lysosomes 
 
 
Until recently, lysosomes were considered the endpoint of the endocytic and autophagic pathways, 
to where cargo and organelles converge to be degraded. However, in recent years, several reports have 
shown that lysosomes are dynamic organelles (Luzio et al., 2014; Samie and Xu 2014) that can undergo 
Ca2+-regulated exocytosis, in a mechanism similar to LROs, in non-specialized cells such as fibroblasts 
and epithelial cells (Rodríguez et al., 1997; Andrews, 2000). Several studies have shown the importance 
of lysosome exocytosis in different cellular functions, namely, in bone resorption, neurite outgrowth, 
secretion and PM repair (Figure I.8) (Samie and Xu, 2014). PM repair is a very important mechanism to 
maintain the integrity of cellular membrane and therefore cell survival. PM disruptions are frequent in 
mechanically-active tissues, like muscle cells (Andrews, 2002) or during pathogen infection. For 
example, the mechanism of Trypanosoma cruzi cell invasion is known to be dependent on lysosome 
exocytosis (Rodríguez et al., 1997). 
Interestingly, only a small fraction of the lysosome population is able to undergo regulated 
exocytosis, pointing to an heterogeneous spatial distribution of lysosomes in the cell (Rodríguez et al., 
1997). Recently two distinc lysosomal populations have been described (Johnson et al., 2016; 
Gowrishankar and Ferguson, 2016). One population that localizes at the perinuclear region and is more 
acidic and a second pool, less acidic that localizes close to the PM (Johnson et al., 2016; Gowrishankar 
and Ferguson, 2016). Since lysosomes that are closer to the PM are the ones prone to fuse (Jaiswal et 
al., 2002), it is likely that the luminal pH of the different population of lysosomes is important for the 
lysosomal exocytosis process (Johnson et al., 2016; Gowrishankar and Ferguson, 2016). In other words, 
a less acidic pH favors the exocytic process. 
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Although lysosomal exocytosis was initially observed in Chinese Hamster Ovary (CHO) and Normal 
Rat Kidney Epithelial Cells (NRK) fibroblasts it is now accepted as an ubiquitous mechanism present in 
all cell types (Andrews 2000). Despite the physiological importance of conventional lysosome 
exocytosis, the molecular mechanism by which it occurs is commonly compared to the synaptic vesicle 
and LRO exocytosis mechanisms, but is far from being fully understood. Lysosome exocytosis depends 
on stimulation and requires specific machinery necessary for the transport of lysosomes from the 
perinuclear region to the cell periphery, for the tethering and docking of lysosomes to the PM and for 
the fusion and release of the lysosomal content to the extracellular space, in a mechanism that has to 
be tightly regulated.  
Lysosomes accumulate at the perinuclear region, around the microtubule-organizing center 
(MTOC) (Matteoni and Kreis, 1987). Lysosomal long range transport from the perinuclear region to the 
cell periphery was shown to be a Ca2+-independent mechanism (Jaiswal et al, 2002) and occurs in a 
bidirectional manner along microtubules. Moreover, this type of transport is mediated by motor proteins 
such as kinesins and dyneins (Matteoni and Kreis, 1987). In MCF-7 breast cancer cells, kinesin 5B 
(KIF5B) was found to associate with lysosomes and the silencing of KIF5B induces peripheral 
aggregations of lysosomes (Cardoso et al., 2009). Also, lysosome localization at the cell periphery is 
known to be mediated by the Arf small GTPase Arl8b, SifA kinesin-interacting protein (SKIP) and 
kinesin-1 (Hofmann and Munro, 2006; Bagshaw et al, 2006; Rosa-Ferreira and Munro, 2011). Recently, 
BLOC-1-related complex (BORC) was described to have an important role in the recruitment of Arl8b to 
the lysosomal membrane, enabling the coupling with SKIP-kinesin complex and the movement to the 
periphery (Pu et al., 2015). Additionally, Rab7, is known to bind to FYVE and coiled-coil domain-
containing 1 protein (FYCO 1), mediating kinesin-dependent transport of lysosomes towards the 
periphery (Pankiv et al., 2010).  
Due to the presence of a cortical actin meshwork beneath the PM, lysosomes also undergo short 
range movement in a process that is likely mediated by actin motors. Recently, our group showed that 
Rab3a, which is involved in exocytic processes, recruits the actin motor non-muscle myosin heavy chain 
Figure I.8 - Biological functions that require lysosome exocytosis. - Lysosome exocytosis is an important 
mechanism in all cell types. It is involved in several cellular functions, namely PM repair, secretion, phagocytosis 
and neurite outgrowth. Taken from Samie and Xu, 2014.  
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IIA (NMHC IIA) to lysosomes. This interaction allows lysosomes to travel through the cortical actin and 
be positioned closer to the PM (Encarnação et al., 2016). After this step, lysosomes must be tethered 
and docked to the PM. The Rab3a effector protein synaptotagmin-like protein 4-a (Slp4-a) is likely 
involved in remodeling cortical actin to allow lysosomes to tether and dock to the PM (Encarnação et 
al., 2016). 
SNARE proteins are involved in the final steps of lysosomes exocytosis, more precisely in lysosome 
fusion with the PM. The vesicle-associated membrane protein 7 (VAMP7) localizes in the lysosomal 
membrane and interacts with Syntaxin-4 and synaptosome-associated protein of 23 kDa (SNAP-23) on 
the PM, forming a trans-SNARE complex (Rao et al., 2004), which primes the lysosomes to fuse with 
the PM. The fusion of lysosomes with the PM is triggered by an increase in intracellular Ca2+ 
concentration that can be induced by membrane disruption, or artificially by Ca2+  ionophores (Rodríguez 
et al., 1997; Andrews 2000;  Reddy et al., 2001). Synaptotagmin VII (Syt VII), a high affinity Ca2+ sensor, 
was found to regulate this step. Syt VII is ubiquitously expressed, localizes to lysosomes and was shown 
to bind to Syntaxin-4 at low Ca2+ concentrations, promoting membrane fusion and lysosomal exocytosis 
(Martinez et al., 2000; Andrews, 2000). However, the precise mechanism by which Syt VII promotes 
lysosome fusion with PM is still not clear. 
The Ca2+ channels that mediate Ca2+- triggered lysosome exocytosis are not fully known, but the 
transient receptor potential channels (TRPML), namely TRPML1, seem to be involved (Samie and Xu, 
2014). Additionally, overexpression of the transcription factor TFEB, which regulates the expression of 
several lysosomal genes such as TRPML1, was shown to increase the docking and fusion of lysosomes 
with the PM (Medina et al., 2011; Settembre et al., 2013; Samie and Xu, 2014), suggesting a role for 
TFEB in lysosome exocytosis. Importantly, this role might not be restricted to the regulation of TRPML1 
but it can also be involved in the positioning of lysosomes near the PM, by  increasing the expression 
and activity of tethering and motor proteins (Medina et al., 2011; Samie and Xu, 2014). 
Lysosome exocytosis was found to be negatively regulated by Neuraminidase 1 (Neu1). Neu1 is 
responsible for post-translational modifications in lysosomal proteins, namely LAMP1. Although the role 
of Neu1 in lysosome exocytosis is not clear, in its absence lysosomal docking and exocytosis increases, 
in a LAMP1-dependent manner (Yogalingam et al., 2008; Samie and Xu, 2014). 
Although several molecules have already been identified to play a role in lysosome exocytosis, the 
full molecular machinery required for the different steps of lysosome transport, tether and fusion with 
the PM is still far from being completely elucidated. The involvement of other important players, including 
Rab GTPases in this mechanism should not be excluded, due their importance in all intracellular traffic 
pathways.  
Because of the biological importance of lysosomal exocytosis and the similarities with other exocytic 
processes, namely LRO exocytosis, it is not surprising that disturbance in lysosome and/or LROs 
pathways can lead to human diseases. 
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 Diseases of lysosomes and lysosome-related organelles  
 
 
Dysfunction of conventional lysosomes, including deficiencies in the lysosomal hydrolytic enzymes, 
generally gives rise to a group of metabolic disorders collectively known as lysosomal-storage disorders 
(LSDs). LSDs result from the accumulation of undigested material in lysosomes (Samie and Xu, 2014). 
However, since conventional lysosomes can also undergo regulated exocytosis, it is likely that defects 
in lysosome exocytosis could lead to other human diseases, commonly associated with LROs (Andrews, 
2002).  
Impaired LRO biogenesis and/or exocytosis leads to several human diseases, namely Chediak–
Higashi (CHS), Griscelli (GS) and Hermansky–Pudlak (HPS) syndromes (Seixas et al., 2013).  
CHS results from mutations in the CHS1/LYST gene, which is involved in the transport of cargo to 
lysosomes (Huizing et al., 2008). Patients with CHS manifest hypopigmentation (albinism) (due to 
decreased melanin production in melanocytes), recurrent infections (due to immune deficiency), 
coagulation defects (due to storage pool deficiency) and neurological impairment (Huizing et al., 2008). 
Interestingly, studies in vivo, revealed the presence of enlarged lysosomes in all cells of the animal 
models of CHS (Huynh et al., 2004). Moreover, these enlarged lysosomes had reduced capacity to 
undergo exocytosis and therefore reduced ability to repair PM damages, contributing to the symptoms 
exhibited by these patients (Huynh et al., 2004).  
GS is a rare autosomal recessive disease that results in hypopigmentation and impaired immune 
responses (Huizing et al., 2008). There are three types of GS that result from mutations in each of the 
members of the tripartite complex Rab27a-Melanophilin-Myo Va, known to be involved in melanosome 
positioning near the PM (Huizing et al., 2008; Seixas et al., 2013). GS type 1 is caused by mutations in 
MYO5A, which encodes Myo Va, an actin-dependent motor protein. GS type 2 results from mutations 
in RAB27A, which encodes Rab27a, with roles in melanosome and CTL lytic granules secretion (Sluijs 
et al., 2013). Finally, GS type 3 is caused by mutations in MLPH, encoding Melanophilin, which serves 
as a linker between Rab27a and Myo Va. GS patients show accumulation of melanosomes in the 
perinuclear region of melanocytes but not enlarged conventional lysosomes (Huizing et al., 2008), thus, 
the role of conventional lysosomes in the pathogenesis of GS, if any, remains elusive.  
HPS is a group of rare autosomal recessive diseases. There are eight human genes whose 
mutations are known to cause HPS (Huizing et al., 2008; Seixas et al., 2013). HPS patients exhibit 
hypopigmentation and bleeding diathesis (Huizing et al., 2008), due to impaired melanosome biogenesis 
and platelet aggregation, respectively (Huizing et al., 2008; Seixas et al., 2013). Accumulation of 
undigested lipids also occur in patients with HPS, because cells cannot rapidly degrade mistargeted 
vesicle membranes, suggesting the involvement of conventional lysosomes in the pathology of some 
types of HPS (Huizing et al., 2008). 
The role of lysosome exocytosis in several cellular processes suggests that impaired lysosome 
exocytosis might have a role in other diseases, not related with LROs. Interestingly, recent studies 
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regarding tumor cell invasion, revealed that increased lysosomal exocytosis promotes extracellular 
matrix invasion and degradation and could promote a cell migratory phenotype (Machado et al., 2015). 
Despite being now accepted that conventional lysosomes can undergo Ca2+-regulated exocytosis 
and that this process is relevant in several cellular functions, namely in PM repair, further studies need 
to be performed to elucidate the role of regulated lysosome exocytosis in human disease.  
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3. Previous results  
 
In recent years, it has been established that lysosomes, similar to LROs can undergo regulated 
exocytosis. However, little is known about the molecular machinery that regulates this pathway. In order 
to identify new regulators of Ca2+-triggered lysosome exocytosis, our group, in collaboration with others, 
performed a lentiviral short-hairpin RNA (shRNA) screen, targeting the major families of membrane 
trafficking regulators (Encarnação et al., 2016). For this, the human monocytic cell line THP1 was 
transduced with lentiviral shRNA hairpins and then stimulated with the Ca2+ ionophore ionomycin, to 
increase intracellular Ca2+ concentration. Lysosome exocytosis was analysed by measuring the cell 
surface expression of the LE/lysosome marker LAMP1, by flow cytometry. Several trafficking regulators 
were found to impair lysosome exocytosis when silenced and interestingly, the majority were Rab 
GTPases. Surprisingly, the silencing of Rab11b, which has described roles in endocytic recycling traffic, 
was found to impair lysosome exocytosis (unpublished data, Encarnação et al., 2016) ). The involvement 
of Rab11b, and its isoform Rab11a in lysosome exocytosis was further confirmed in HeLa cells (human 
cervical cancer cells). Indeed, our group observed that the silencing of Rab11a or Rab11b impairs 
LAMP1 cell surface expression levels and decreases the release of the lysosomal hydrolytic enzyme β-
hexosaminidase, upon ionomycin stimulation, when compared with non-transduced (NT) cells, cells 
treated with an empty vector (Empty), or cells treated with a non-targeting shRNA (Mission) (Figure I.9, 
A/B unpublished). Furthermore, HeLa cells transduced simultaneously with Rab11a and Rab11b 
shRNAs do not show a higher decrease in LAMP1 surface expression and β-hexosaminidase release, 
upon ionomycin stimulation, when compared with HeLa cells transduced with only Rab11a or Rab11b 
shRNAs (Figure I.9 A/B, unpublished). These results suggest a role for the endocytic recycling pathway 
in Ca2+-regulated lysosome exocytosis, and that Rab11a and Rab11b do not have redundant functions 
and probably act in different steps of the pathway.  In fact, Rab11 and the endocytic recycling pathway 
have been linked before with the exocytosis of LROs. Indeed, our group showed that Rab11b plays a 
role in melanosome exocytosis from melanocytes (Tarafder et al., 2014). Moreover, during lytic granule 
secretion by CTLs, it was proposed that Rab11-positive vesicles interact with immature vesicles, and 
deliver proteins required for  the late stages of exocytosis (Sluijs et al., 2013). Nevertheless, the role of 
Rab11 in lysosome exocytosis remains elusive.  
 
 
 
 
 
18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure I.9 - LAMP1 cell surface expression levels and β-hexosaminidase release in HeLa cells silenced for 
Rab11a, Rab11b or both. HeLa cells transduced with lentiviruses encoding shRNAs for Rab11a, Rab1b or both 
were selected for 6 days in puromycin. Cells were the treated with 10 µM ionomycin and 4 mM CaCl2 for 10 minutes 
at 37ºC, to trigger lysosome exocytosis. A. Cells were collected and stained with an anti-LAMP1 antibody. Non-
transduced cells (NT), cells transduced with an empty vector (empty) and cells transduced with a non-targeting 
shRNA (Mission) were used as negative controls. The results are presented as percentage (%) of cells positive for 
LAMP1 and negative for propidium iodide (LAMP1+/PI-). All results were normalized to empty (100%) and are 
represented as mean ± SD. B. Cellular extracts and supernatants containing released β-hexosaminidase were 
collected and analysed. Non-transduced cells (NT), cells transduced with an empty vector (Empty) and cells 
transduced with a non-targeting shRNA (Mission) were used as negative controls. The results are presented as 
percentage (%) of released β-hexosaminidase. All results were normalized to empty (100%) and are represented 
as mean ± SEM 
A B 
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4. Objectives 
 
Since Rab11, similar to other Rab GTPases, exerts its function through the interaction with effector 
proteins, the role of Rab11 in the regulation of lysosome exocytosis is likely dependent on proteins that 
interact with Rab11.  
Thus, the main objective of this thesis was to find proteins that interact with Rab11 and play a role 
in Ca2+-triggered lysosome exocytosis. Moreover, we want to characterize spatially and temporally the 
intersection between the endocytic recycling pathway and the lysosome exocytosis process. 
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II. Materials and Methods 
 
1. Cell culture 
 
HeLa human cervical cancer cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM, 
Gibco), supplemented with 10% heat-inactivated fetal bovine serum (FBS, Gibco), 100 U/mL 
penicillin/streptomycin (Gibco), 2 mM L-glutamine (Gibco) and 20 mM HEPES (Gibco), and kept at 37ºC 
in a 5% CO2. 
 
2. Gene silencing 
 
Rab11 effectors were silenced using siGENOME SMARTpool Oligos (Thermo Scientific 
Dharmacon) specific for human genes. The list of small interfering RNA (siRNA) sequences is described 
in Table 1. As a control, a non-targeting siRNA sequence (siControl) (Thermo Scientific Dharmacon) 
was used. HeLa cells (7x104 cell/well) were seeded 24 hours before transfection, in 24 well-plates using 
DMEM supplemented as described above, without antibiotics. Transfection was performed using 40 nM 
of siRNA and 2 µL of transfection reagent DharmaFECT 1 (Dharmacon) in 100 µL of Opti-MEM (Gibco), 
as indicated by the manufacturer. Twenty-four hours after the silencing, the transfection medium was 
replaced by complete DMEM. All assays were performed 72 hours after siRNA transfection. 
 
                                              Table II.1 - siRNAs used for silencing Rab11 effectors 
 
Gene siRNA sequence 
siControl UAAGGCUAUGAAGAGAUAC 
 
siFIP1-C 
CAAACAGAAGGAAACGAUA; 
GCUAACUGCAGCUUGGGAA; 
AGUGAGAACUUGAACAAUG; 
UCCGCGAGCUGGAAGACUA. 
 
siFIP2 
GGAUGAAGGUGAAUUGUGU; 
CGAGCUACCUGGAUUGCUA; 
GGAACAAUAUGACCGCAAG; 
GAUAAGAUGAAGGGUAGAA. 
 
siMyosin Va 
GAACAAAUGUGCACUCUUU; 
GAUCAUCUGCUCUGGAUUA; 
AAAGUAAGGUCGUUGCUAA; 
CGCAGGAGGUACAAGAUUA. 
 
siMyosin Vb 
GGACUUACCUCUUGGAGAA; 
CAAGUUGGCCUAACAGUGA; 
GCAGAUCUGGCCUACAAUA; 
ACAGUGGCCUUUAUACGAA. 
 
siSec8 
GAAUUGAGCAUAAGCAUGU; 
UAACUGAGUACUUGGAUAU; 
GCCGAGUUGUGCAGCGUAA; 
ACUGAGUGACCUUCGACUA. 
 
siSec15 
UAACUGAACUGCUGAAAGU; 
GUACUAGUCCGAAGUCUGA; 
CAAGUAAGCCACUAUCGAU; 
CGGGAAACAUUUGAGAAUU. 
 
siExo70 
GGUUAAAGGUGACUGAUUA; 
GACCUUCGACUCCCUGAUA; 
CUAAGCACCUAUAUCUGUA; 
CGGAGAAGUACAUCAAGUA. 
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3. Cell transfection 
 
HeLa cells were seeded, 24 hours before transfection in DMEM supplemented as described above, 
without antibiotics or FBS. The cells were transfected with 1 µg DNA and 2 µL Lipofectamine 2000 
(Invitrogen) in 24-well plates, 10 µg DNA and 20 µL Lipofectamine 2000 in 10 cm dishes or 0.5 µg DNA 
and 1 µL Lipofectamin 2000 in Nunc™ Lab-Tek™ Chambered Coverglasses (ThermoFisher Scientific), 
in Opti-MEM, according to manufacturer’s instructions. DNA plasmids used are summarized Table 2. 
Five hours after transfection, medium was replaced by complete DMEM and cells were analysed 24 
hours later. 
 
                                 Table II.2 - DNA plasmids used to transfect HeLa cells. 
 
Gene Plasmids 
GFP alone pENTR GFP vector. 
Rab11a 
mRab11a GFP; 
pCDNA-ENTR-BP-cherry mRab11a. 
Rab11b 
pENTR GFP C2 mRab11b; 
pCDNA-ENTR-BP-cherry mRab11b. 
FIPs 
pEGFP-N1-FIP1C/RCP; 
pEGFP-N3-FIP2-GFP; gift from R.Prekeris 
Myosin V Myosin Va-GFP, gift from Dra. M. João Amorim; 
Exocyst subunits 
pGFP-N1 Sec8 
pJ3 Myc-EGFP rat Sec15; 
pEGFP-C1 rat Exo70; 
pCDNA3.1 Exo70-cherry. 
 
 
4. RNA extraction, cDNA production and real-time quantitative PCR 
 
RNA from HeLa cell lysates was extracted using the RNeasy Mini Kit (Qiagen) according to the 
manufacturer’s instructions. RNA was reverse-transcribed into complementary DNA (cDNA), by 
incubating 1 µg of total RNA with 1 mM of dNTP mix (Thermo Scientific) and 0.3 µg/uL of random primers 
p(DN) (Roche) at 65ºC for 5 min. After placing samples for a few seconds on ice, they were incubated 
with 2x first strand buffer (Invitrogen), 20 mM DTT (Invitrogen) and 40 U/µL of Recombinant 
Ribonuclease Inhibitor RNaseOUT (Invitrogen) at 25ºC for 2 minutes. Finally, 50 U/µL of Superscript II 
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Reverse Transcriptase (Invitrogen) were added and samples were incubated at 25ºC for 10 minutes, 
42ºC for 50 minutes and finally at 70ºC for 15 minutes. 
To perform real-time quantitative PCR (qRT-PCR), Fast Start Essential DNA Green Master (Roche) 
kit was used according to the manufacturer’s instructions. Analysis was done in the qPCR Roche Light 
Cycler. Βeta-actin, a housekeeping gene, was used as an endogenous control to normalize the 
expression level of each gene analysed. Primers used are summarized in Table 3. 
 
                                   Table II.3 - Primers used in qRT-PCR assays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Immunoprecipitation   
 
Cells were lysed with ice-cold modified radioimmunoprecipitation lysis buffer (RIPA) (50 mM Tris- 
HCl pH 7.5; 1 mM EDTA; 1 mM EGTA; 150 mM NaCl; 2 mM MgCl2; 1 mM DTT; 1% IGEPAL) containing 
protease (0.5 x) and phosphatase (0.5 µM) inhibithors, for 30 minutes at 4˚C, under constant agitation. 
After centrifugation at 18,800 x g for 30 minutes, at 4˚C, supernatants were collected and protein 
concentration was determined using DC protein assay kit (Bio-Rad), according to the manufacturer’s 
instructions. 
Gene Primer sequence 
Actin B 
Forward 5’-GCAAAGACCTGTACGCCAAC-3’ 
Reverse 5’-AGTACTTGCGCTCAGGAGGA-3’ 
FIP1-C 
Forward 5’-CAAGGAGCGAGGAGAAATTG-3’ 
Reverse 5’-GGTGTCTGACCCACTGTCCT-3’ 
FIP2 
Forward 5’-TGGGGGATCTGATAGCCCTT-3’ 
Reverse 5’-ACTCATATGAAAACTTGAAGATGGC-3’ 
Sec8 
Forward 5’-ATGGCCAGCAAGCACTATCT-3’ 
Reverse 5’-AGGTGCCGGTGTAGTTCATC-3’ 
Sec15 
Forward 5’-CTGACCCTGCTTGAGAAGATGA3’ 
Reverse 5’-GCCACGGTGTCAATGAGTTTC-3’ 
Exo70 
Forward 5’-CATGGGTTATCAGGGGATTTG-3’ 
Reverse 5’-GAGGTCCAGGTGTGGGTAGA-3’ 
Myosin Va 
Forward 5’-CAGTGGTCAGAACATGGGTG-3’ 
Reverse 5’-TCGCATGGCATACTTAGCTG-3’ 
Myosin Vb 
Forward 5’-AGAACTGGAGGAGGAGCGAT-3’ 
Reverse 5’-GGTTTGATGGGTTCCGCCTA-3’ 
24 
 
For Rab11a and Rab11b endogenous immunoprecipitation, 800 to 1,000 µg of total protein were 
pre-cleared for 1 hour with ProteinG-Sepharose beads (Sigma), at 4ºC, with agitation. 
Immunoprecipitation was performed overnight at 4ºC, using 0.71 µg of rabbit anti-Rab11a (Abcam) or 2 
µg of rabbit anti-Rab11b (Abgent) antibodies, and the same concentration of rabbit IgG (M8645, Sigma-
Aldrich), used as a negative control. ProteinG-Sepharose beads were then added and incubated for 5 
hours at 4ºC, under constant agitation. Samples were then centrifuged at 21,100 x g, for 5 minutes, at 
4ºC and the supernatant was discarded. The beads were washed twice in RIPA with 500 mM NaCl, and 
three in RIPA with 150 mM NaCl. Finally, samples were solubilized in 20 µL of Laemmli sample buffer 
2x concentrated, boiled at 95ºC for 5 minutes and centrifuged at maximum speed. 
For immunoprecipitation of GFP-fusion proteins, HeLa cells (2 x 106 cells) were seeded in 10 cm 
dishes 24 hours before transfection with Rab11a/b-mCherry, Sec15-GFP or GFP-vector as described 
previously. Twenty-four hours after transfection, cells were collected, lysed and protein was quantified 
as described above. GFP-Trap Beads (ChromoTek) were equilibrated in 150 mM RIPA, before 
incubation with 800 µg of total cell extracts for 2h at 4ºC. The samples were then centrifuged at 2,500 x 
g for 3 minutes at 4ºC, and supernatants discarded. The beads were washed twice with RIPA containing 
500 mM NaCl, and three times with RIPA with 150 mM NaCl. Finally, samples were solubilized in 20 µL 
of Laemmli sample buffer 2x concentrated, boiled at 95ºC for 5 minutes and centrifuged at maximum 
speed. 
Protein analysis was performed in a 10% SDS-PAGE gel, followed by immunoblotting 
 
 
6. Immunoblotting 
 
Proteins separated by SDS-PAGE were transferred to a PVDF 0.2 µm membrane (Milipore) or 
Nitrocellulose (GEHealtcare Life Sciences) for 55 minutes at 100V, in transfer buffer (25 mM Tris; 192 
mM glycine; 0,5% SDS; 20% ethanol 96%). Membranes were blocked with blocking solution (5% milk 
in PBS with 0,1% Tween-20), for 1 hour at room temperature, before primary antibody incubation in a 
humidified chamber, for 2 hours at room temperature. Primary antibodies used for immunoblotting are 
described in Table 4. Membranes were then washed 3 times, for 5 minutes, with PBS + 0,1% Tween-
20 and incubated with HRP-conjugated secondary anti-rabbit, anti-mouse or anti-goat antibodies (1: 
5,000) (Amersham ECL Rabbit, Mouse or Goat IgG, HRP-linked whole Ab, GE Healthcare), for 1 hour 
at room temperature under constant mixing. Membranes were washed 3 times for 10 minutes and 
antibody detection was accomplished with Amersham ECL Select (GE Healthcare), according to the 
manufacturer’s instructions. Chemiluminescence was detected using ChemiDoc™ Touch Imaging 
device and the results were analysed using ImageLab software. 
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                          Table II.4 - Primary antibodies used for Immunobloting 
 
Primary antibodies Host Animal  Immunoblotting dilution 
Rab11a (Abcam) 
(ab128913) 
Rabbit 1:50,000 
Rab11b (Abgent) 
(# AP12943b) 
Rabbit 1:1,000 
FIP 2 (Abcam) 
(ab76892) 
Rabbit 1:650 
Sec 5 (Novus) 
(NBP1-83786) 
Rabbit 1:500 
Sec8 (Enzo Life Sciences) 
(clone 14G1, ADI-VAM-SV016-F) 
Mouse 1:500 
Sec 15 (Sigma-Aldrich) 
(clone 15S2G6, SAB 4200612) 
Mouse 1:1,000 
Exo 70 (Milipore) 
(clone 70X13F3, MABT186) 
Mouse 1:1,000 
GFP (AB 0020-200) 
mCherry (AB 0040-200) 
(Sicgen) 
Goat 1:1,000 
 
 
7. β-hexosaminidase release assay  
 
HeLa cells silenced for 48 hours with different siRNA smartpools were replated (4 x 105 cells/well) 
in 6-well plates. As controls, HeLa cells without siRNA transfection (NT) or with Dharmafect reagent only 
(mock), were also replated. 
Twenty-four hours after replating the cells and 72 hours after siRNA silencing, cells were washed 
with Ca2+- and Mg2+- free ice-cold Hanks Balanced Salt Solution (HBSS, Gibco) and incubated with 
HBSS with or without 10 µM ionomycin and 4 mM CaCl2, for 10 minutes at 37ºC. The samples were 
placed on ice and cell supernatants containing released β-hexosaminidase were collected. In parallel, 
cells were lysed with 1% IGEPAL and further diluted 1:5 in dH2O. 
All samples were centrifuged for 5 minutes at 11,000 x g, at 4ºC, and supernatants were collected. 
β-hexosaminidase activity was determined by incubating diluted cell lysates (100 µL) or cell supernatant 
(100 µL) with 6 mM of the enzyme substrate 4-methyl-umbelliferyl-N-acetyl-β-D-glucosaminide 
(Glycosynth) diluted in 40 mM sodium citrate, 88 mM Na2PO4, pH 4.5, for 30 minutes at 37ºC. 
Fluorescence was measured in an Infinite F200 Pro reader (Tecan) at an excitation wavelength of 365 
nm and emission wavelength of 450 nm. The protein content from all cell lysates and supernatants was 
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determined simultaneously, using the BCA protein kit (Pierce Laboratories). Absorbance was measured 
at 560 nm in the same plate reader. HBSS and 1% IGEPAL diluted 1:5 were used as controls. 
β-hexosaminidase (βhex) activity in supernatant and cell lysates was calculated for each sample 
normalizing to protein quantity as follows: 
βhex activity in supernatant = (fluorescence (365/450) - HBSS alone) / protein µg 
βhex activity in cell lysate = (fluorescence (365/450) - IGEPAL alone) / protein µg 
Total β-hexosaminidase activity was determined as following:  
Total βhex activity = βhex activity in supernatant + 5x βhex activity in cell lysate 
Finally, the percentage of β-hexosaminidase release was calculated: 
βhex release (% of total) = 100 x (βhex activity in the supernatant / total βhex activity) 
 
 
8. LAMP1 cell surface expression  
 
HeLa cells silenced for 48 hours with different siRNA smartpools were replated (1 x 105 cells/well) 
in 24-well plates. As controls, HeLa cells without siRNA transfection (NT) or with Dharmafect reagent 
only (mock), were also replated. 
Twenty-four hours after replating the cells, and 72 hours after siRNA silencing, cells were washed 
with Ca2+- and Mg2+-free ice-cold HBSS and incubated with or without 10 µM ionomycin and 4 mM CaCl2 
for 10 minutes at 37ºC. Cells were placed on ice and collected in 500 µL ice-cold flow cytometry buffer 
(1% FBS, 2mM EDTA in 500 mL PBS). Cells were then centrifuged at 300 x g, for 5 minutes at 4º C and 
washed once with flow cytometry buffer. For LAMP1 detection, cells were incubated with mouse anti- 
LAMP1 conjugated with Alexa Fluor 488 antibody (clone H4A3, BioLegend) diluted 1: 1,000, for 30 
minutes on ice, protected from the light. Samples were washed once, centrifuged and resupended in 
flow cytometry buffer. To exclude dead cells, samples were incubated with 0.5 µg/mL of propidium iodide 
(PI) (Sigma-Aldrich) just before acquisition. Acquisition was performed in a FACS CANTO II flow 
cytometer, and at least 20,000 cells were analysed using FlowJo version 10.1r7 software. 
 
 
9. Immunofluorescence microscopy  
 
HeLa cells (1x105 cells/well) were seeded on glass coverslips and transfected or not 24 hours later, 
as described previously. Twenty-four hours after transfection, medium was removed and cells were fixed 
with 4% PFA (Alfa Aesar) for 20 minutes at room temperature. Cells were washed 3 x with PBS and 
blocked/permeabilized with Perblock (1% BSA, 0,05% saponin in PBS) for 30 minutes at room 
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temperature, before incubation with the primary antibodies rabbit anti-Rab11a (Abcam) (1:500), rabbit 
anti-Rab11b (Abgent) (1:100) or mouse anti-LAMP1 conjugated with Alexa fluor 488 (clone H4A3, 
BioLegend) (1:500), diluted in Perblock and incubated for 1 hour, at room temperature in a humidified 
chamber. Coverslips were washed 3 x with PBS and incubated with secondary Alexa Fluor goat anti-
mouse or anti -rabbit 488, 568 or 647 (1:500) (Invitrogen), diluted in Perblock, for 30 minutes at room 
temperature in a humidified chamber. After 3 washes with PBS, cells were incubated with DAPI (1 µg/mL 
Sigma) for 5 minutes. Finally, coverslips were washed 3 x with PBS and mounted in Mowiol mounting 
media (Calbiochem). Images were acquired in a Zeiss LSM 710 confocal microscope with a Plan-
Apochromat 63x1.4 NA oil-immersion objective and analysed with ImageJ software. 
 
 
10. Live cell-imaging 
 
HeLa cells (4 x 104 cells/well) were plated in Nunc™ Lab-Tek™ Chambered Coverglasses 
(ThermoFisher Scientific) with 200 µL of DMEM supplemented as described before, without antibiotics. 
Twenty-four hours after transfection with Rab11a/Rab11b or Sec15, cells were incubated with 50 nM 
LysoTracker® Red DND-99 (Invitrogen) for 1 to 2 hours. Cells were then washed with PBS and kept in 
phenol red-free DMEM (Gibco) for imaging. Cells were imaged without stimulation and when indicated 
were also imaged after adding 4 µM ionomycin and 4 mM CaCl2. Live-cell imaging was performed at 
37ºC using an Andor Revolution spinning disk confocal microscope (Andor Technology) equipped with 
an EMC CD camera with a Plan Apo VC PFS 60x objective (1.4 NA oil-immersion; Nikon). The system 
was controlled by iQ software (Andor Technology) and images were analysed using ImageJ software. 
 
 
11. Statistical analysis 
 
Numerical data are presented as Mean ± Standard Deviation (SD) for LAMP1 cell surface 
expression levels and Mean ± Standard Error of the Mean (SEM) for β-hexosaminidase release. One-
way ANOVA (Dunnett’s multiple comparison test), was used to compare different data sets with 
siControl. Statistical analysis was performed using GraphPad Prism version 6.05. 
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III. Results 
 
1. Identification of Rab11a/b effectors required for lysosome exocytosis  
 
Previous results from our group have shown that the silencing of Rab11a or Rab11b impairs Ca2+-
triggered lysosome exocytosis in HeLa cells (Figure I.9). However, the mechanism by which Rab11a 
and Rab11b regulate this pathway is not clear. To understand how Rab11a/b play a role in the transport, 
docking and/or fusion of lysosomes with the PM, we searched for Rab11 effector proteins that can 
mediate these functions. To accomplish this, we started by transfecting HeLa cells with siRNAs targeting 
effector proteins described in the literature as interacting with Rab11a and/or Rab11b. We selected the 
FIPs, since they are the best described Rab11 interacting partners; Myo Va and Myo Vb, due to their 
important roles in the movement of Rab11-positive vesicles along the actin cytoskeleton; and the 
exocyst, an octameric complex involved in the tethering of vesicles to the PM. We tested the exocyst 
subunits Sec8, Exo70 and Sec15, which was described to interact directly with Rab11a (Zhang et al., 
2004). 
To induce lysosome exocytosis, the cells were stimulated with 10 µM of the Ca2+ ionophore 
ionomycin for 10 minutes, in the presence of 4 mM CaCl2. As a readout, the presence of the 
LE/lysosome marker LAMP1 at the cell surface was assessed by flow cytometry, using an antibody 
against the luminal epitope of LAMP1. Cells that stained with propidium iodide (PI) were discarded, 
since they were considered as dying/dead cells and lysosome exocytosis efficiency was determined by 
the percentage of LAMP1-positive (LAMP1+) and PI negative (PI-) cells. The results obtained in cells 
silenced for the different effectors were normalized to cells transfected with a non-targeting siRNA 
(siControl). Upon ionomycin stimulation, we observed that all cells show a positive shift in LAMP1 mean 
luorescence intensity (MFI) (Figure III.1, A) that translated into an increase in the percentage of 
LAMP1+/PI- cells (Figure III.1, B) compared with the non-stimulated cells. This indicates that cells were 
able to undergo Ca2+-triggered lysosome exocytosis.  
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The cells transfected with siControl showed similar levels of LAMP1 surface expression compared 
with non-transfected HeLa cells (HeLa NT) and cells treated with the transfection reagent (Mock) (Figure 
III.2, A). Interestingly, upon ionomycin stimulation, the silencing of Sec15 results in a significant 
decrease in LAMP1 cell surface expression levels, when compared with control cells (Figure III.2, A). 
These results are similar to what was observed by our group in the absence of Rab11a or Rab11b 
(Figure I.9, A) and suggest that Sec15 is required for lysosome exocytosis. Noteworthy, the silencing of 
Sec8 or Exo70, two other subunits of the exocyst complex, do not affect significantly LAMP1 cell surface 
expression levels (Figure III.2, A). Therefore, our results point to a role for Sec15 in lysosome exocytosis 
that is independent of the exocyst complex.  
The silencing of FIP1-C or FIP2 results in a significant increase in LAMP1 cell surface expression 
levels (Figure III.2, A), suggesting that these FIPs negatively regulate lysosome exocytosis. Similarly, in 
the absence of Myo Vb, we observed an increase in LAMP1 expression levels at the cell surface (Figure 
III.2, A). The silencing of Myo Va has no effect on lysosome exocytosis upon ionomycin stimulation 
(Figure III.2, A).  
The mRNA expression levels of Rab11 effectors were quantified by qRT-PCR relatively to a 
housekeeping gene, β-actin (Figure III.2, B). The silencing efficiency was always 50% or more when 
compared to siControl. Besides FIP1C and FIP2, FIP3 and FIP5 were also tested, but we could not 
silence them more than 50%. Therefore, the analysis with these FIPs was not carried further.  
Figure III.1 - Ionomycin treatment increases LAMP1 cell surface expression in HeLa cells. A.  HeLa cells were 
treated with 10 µM ionomycin and 4 mM CaCl2, in HBSS, for 10 minutes at 37ºC, to trigger lysosome exocytosis 
and with HBSS alone (no ionomycin). Cells were collected, stained with an anti-LAMP1 antibody and analysed by 
flow cytometry. Unlabeled (No Ab) cells were used as negative controls. LAMP1 mean fluorescence intensity (MFI) 
is represented. B. Results are shown as percentage of LAMP1+/PI- cells and are presented as mean ±SD. 
B A 
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Figure III.2 - LAMP1 cell surface expression levels in HeLa cells silenced for FIP1-C, FIP2, Myosin Va, 
Myosin Vb, Sec8, Sec15 or Exo70.  A. HeLa cells transfected with siRNAs for the indicated Rab11a/b effectors 
were treated with 10 µM ionomycin and 4 mM CaCl2 for 10 minutes at 37ºC, to trigger lysosome exocytosis. Cells 
were collected, stained with an anti-LAMP1 antibody and analysed by flow cytometry. Non-transfected cells (NT), 
cells treated with transfection reagent (Mock) and cells transfected with a non-targeting siRNA (siCont) were used 
as negative controls. The results are presented as percentage (%) of cells LAMP1+/PI-. All results were normalized 
to siControl (100%) and are represented as mean ± SD.  B. Relative expression of Rab11a/b effectors mRNA. 
Rab11a/b effectors were silenced as described in Materials and Methods. The relative expression of each silenced 
gene was analysed by qRT-PCR and normalized to the expression of β-actin, a housekeeping gene. All results 
were normalized to siControl (1.0) and are represented as mean ± SD. Error bars represent SD from three or more 
independent experiments.  
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To confirm that the differences in LAMP1 expression at the cell surface caused by the silencing of 
Rab11a/b effectors are the result of defects in lysosome rather than LE exocytosis, we used a different 
readout and measured the release of the lysosomal hydrolytic enzyme β-hexosaminidase. First, we 
confirmed that the stimulation of HeLa cells with ionomycin increases β-hexosaminidase release, when 
compared with non-stimulated cells (Figure III.3).  
 
 
 
 
 
 
 
 
 
 
However, upon ionomycin stimulation, HeLa cells transfected with a non-targeting siRNA sequence 
(siControl), normally used as a control to normalize all samples, showed a reduction in β-
hexosaminidase release relative to non-transfected cells (NT) and mock-transfected cells (Mock) 
(Figure III.4, A). This suggests that the non-targeting sequence impairs the release of β-hexosaminidase 
or that the treatment with siRNAs in general induces this effect.  
When compared with siControl, the silencing of Sec15 has no significant effect in the release β-
hexosaminidase (Figure III.4, A). However, when compared with non-transfected or mock-transfected 
cells, the silencing of Sec15 leads to a significant decrease in β-hexosaminidase release. Therefore, it 
is possible that the silencing of Sec15 impairs the release of β-hexosaminidase. The silencing of Sec8 
or Exo70 has no effect in β-hexosaminidase release (Figure III.4, A), similar to what was observed for 
LAMP1 surface levels and further suggests that these exocyst subunits are not involved in lysosome 
exocytosis.  
In agreement with the results obtained for LAMP1 cell surface expression levels, the silencing of 
FIP1C or FIP2 lead to an increase in β-hexosaminidase release, upon ionomycin stimulation (Figure 
III.4, A), confirming that they are negative regulators of lysosome exocytosis. Curiously, the silencing of 
Myo Vb, which leads to an increase in LAMP1 cell surface expression levels, has no effect in the release 
Figure III.3 - Ionomycin treatment increases β-hexosaminidase release in HeLa cells. HeLa cells were 
incubated with 10 μM ionomycin and 4 mM CaCl2, for 10 minutes at 37ºC to induce lysosome exocytosis. Cellular 
extracts and supernatants containing the released β-hexosaminidase were collected and analysed. β-
hexosaminidase release was quantified as described in Materials and Methods. The results are presented as the 
percentage (%) of released β-hexosaminidase and are shown as mean ± SEM. 
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of β-hexosaminidase, indicating that Myo Vb is required for LE exocytosis and not lysosome exocytosis 
(Figure III.4, A).  
Silencing efficiency was monitored, in all assays, by quantifying mRNA expression levels by qRT-
PCR and was higher than 50% for all Rab11a/b effectors (Figure III.4, B).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.4 - β-hexosaminidase release in HeLa cells silenced for FIP1-C, FIP2, Myosin Va, Myosin Vb, Sec8, 
Sec15 or Exo70.  A. HeLa cells silenced with siRNAs for Rab11a/b effectors were treated with 10 µM ionomycin 
and 4 mM CaCl2 for 10 minutes at 37ºC to trigger lysosome exocytosis. Cellular extracts and supernatants 
containing the released β-hexosaminidase were collected and analysed. β-hexosaminidase release was quantified 
as described in Materials and Methods. The results are presented as the percentage (%) of released β-
hexosaminidase. All results were normalized to siControl (100%) and are represented as mean ± SEM. B. Relative 
expression of Rab11a/b effectors mRNA. Rab11a/b effectors were silenced as described in Materials and 
Methods. The relative expression of each silenced gene was analysed by qRT-PCR, and normalized to the 
expression of β-actin, a housekeeping gene. All results were normalized to siControl (1.0) and are represented as 
mean ± SD. Error bars represent SEM (A) and SD (B) from three or more independent experiments.   
A 
B 
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2. Interaction of Rab11a/b with their effectors 
 
The interaction of Rab11a/b with effector proteins has been described in several cell lines using 
different methodologies, namely yeast two-hybrid assays and fluorescence resonance energy transfer 
(FRET) (Lapierre et al., 2001; Hales et al., 2002; Peden et al., 2004; Zhang et al., 2004; Horgan et al., 
2010). In order to confirm that in HeLa cells Rab11a and Rab11b interact with the effector proteins 
studied, we immunoprecipitated endogenous Rab11a or Rab11b from total protein extracts, using 
Protein G Sepharose beads and antibodies that recognize specifically each Rab11 isoform. After protein 
separation in 10% SDS-PAGE, we incubated the membranes with antibodies that recognize specifically 
the exocyst complex components Sec8, Sec15 and Exo70. We found that Sec15, Sec8 and Exo70 co-
immunoprecipitate (co-IP) with both Rab11 isoforms, in HeLa cells (Figure III.5). Sec15 was already 
shown to interact directly with Rab11 in mammalian cells (Zhang et al., 2004) and Sec8 and Exo70 were 
found by our group to co-IP with Rab11b in melanocytes (unpublished). However, Sec15 appears to be 
very sticky, resulting in a strong band in the IgG control. To overcome this issue, and confirm the 
interaction of Rab11a and Rab11b with Sec15, we co-overexpressed Rab11a- or Rab11b-mCherry with 
Sec15-GFP, in HeLa cells. Sec15 was immunoprecipitated using GFP-trap beads, which sequester 
GFP-fused proteins, and the immunoblot was performed using an anti-mCherry antibody to detect 
transfected Rab11a or Rab11b. As expected, both Rab11a- and Rab11b-mCherry co-IP with Sec15-
GFP, confirming the interaction between Rab11 and Sec15 in HeLa cells (Figure III.6). 
 
 
Figure III.5 - Co-immunoprecipitation of endogenous Rab11a and Rab11b with different exocyst complex 
subunits in HeLa cells. Total cell extracts (1 mg) were used to immunoprecipitate (IP) Rab11a or Rab11b, using 
antibodies that recognize specifically each isoform. Rabbit IgG was used as a negative control. Inputs correspond 
to 1/10 of total cell extracts used for IP (100 µg). Immunoblot (IB) was done using mouse anti-Sec8, mouse anti-
Sec15, mouse anti-Exo70, rabbit anti-Rab11a or Rab11b antibodies. The images are representative of two or more 
independent experiments. 
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We also tested if FIP2 interacts with Rab11a and/or Rab11b in HeLa cells. As expected, we were 
able to co-IP endogenous FIP2 and endogenous Rab11a and Rab11b (Figure III.7). We did not test 
FIP1-C because of the lack of a suitable antibody to detect it by Immunoblot. 
In addition, we tried to detect if endogenous Myo Va and Myo Vb interact with Rab11a and/or 
Rab11b, in HeLa cells. However, the antibodies tested were not able to detect the Myosins by 
immunoblot, probably due to the low endogenous expression levels of these proteins.  
 
 
 
 
Figure III.7 - Co-immunoprecipitation of endogenous Rab11a and Rab11b with FIP2 in HeLa cells. Total cell 
extracts (1 mg) were used to immunoprecipitate Rab11a or Rab11b, using antibodies that recognize specifically 
each isoform. Rabbit IgG were used as negative control. Input corresponds to 1/10 of total cell extracts used for 
IP (100 µg). Immunoblot (IB) was done using rabbit anti-FIP2, rabbit anti-Rab11a or rabbit anti-Rab11b antibodies. 
The images are representative of two independent experiments. 
Figure III.6 - Co-immunoprecipitation of Rab11a- or Rab11b-mCherry with Sec15-GFP in HeLa cells. Total 
cell extracts (800 µg) were used to immunoprecipitate (IP) Sec15-GFP, using GFP-trap beads. Cells expressing 
GFP were used as a negative control. Input correspond to 1/10 of total cell extracts used for IP (80 µg). Immunoblot 
(IB) was done using goat anti-mCherry or goat anti-GFP primary antibodies.  
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3. Intracellular localization of Rab11a/b and their effectors  
 
Immunoprecipitation studies have shown that in HeLa cells, Rab11a and Rab11b interact with the 
exocyst complex subunits Sec15, Sec8 and Exo70, as well as FIP2. However, it is important to 
understand where these interactions are occurring within the cell, to infer about their functional role. 
Immunofluorescence microscopy is an important technique to study the intracellular localization of 
proteins and organelles and it can be useful to define spatially where protein-protein interactions are 
likely to occur. 
First, we studied the intracellular localization of both Rab11a and Rab11b in HeLa cells. For that, 
we transfected cells with Rab11a/b-mCherry or Rab11a/b-GFP and analysed them by confocal 
immunofluorescence microscopy. We observed that both Rab11 isoforms are distributed throughout the 
cytoplasm, with a striking accumulation at the perinuclear region, which is the typical localization of the 
endocytic recycling compartment (ERC) (Figure III.8, A). Due to the role of Rab11 in endocytic recycling 
trafficking, its localization at the ERC was expected. Next, we analysed the distribution of endogenous 
Rab11a and Rab11b. For that, we used antibodies that recognize specifically Rab11a and Rab11b 
isoforms. We observed that endogenous Rab11a and Rab11b are distributed throughout the cytoplasm, 
with an accumulation at the perinuclear region, similar to what was observed for the overexpressed 
proteins (Figure III.8, A). This suggests that the fluorescently-tagged proteins can be used to infer about 
the localization of the endogenous proteins. 
Importantly, Rab11a and Rab11b strongly co-localize with each other in HeLa cells, suggesting that 
they localize to the same intracellular organelles and vesicles (Figure III.8, B). This is not surprising 
because they share 90% identity. 
We also studied the intracellular localization of the Rab11a/b effector proteins analysed previously 
and investigated if they co-localize with Rab11a/b, at steady state. For that, we overexpressed the 
effector proteins due to the lack of suitable specific antibodies, and stained the cells for endogenous 
Rab11a or Rab11b (Figure III.9/10). Transfected FIP1-C was found dispersed throughout the cytoplasm 
(Figure III.9/10), but co-localizing with both Rab11a and Rab11b. FIP2-GFP showed a widespread 
distribution all over the cytoplasm (Figure III.9/10) forming small aggregates that were positive for Rab11 
isoforms (Figure III.9/10). Additionally, we observed that the localization of endogenous Rab11a and 
Rab11b was changed when FIPs were overexpressed (Figure III.9/10), suggesting that overexpressed 
FIP1-C and FIP2 mislocalize endogenous Rab11a and Rab11b.  
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Myo Va was found to localize near the cell periphery and to accumulate at the cel tips, where it co-
localizes with Rab11a and Rab11b (Figure III.9/10). Again, the overexpression of Myo Va affected 
Rab11a and Rab11b distribution within the cell, leading to their accumulation at the cell periphery (Figure 
III.9/10). We could not analyse Myo Vb intracellular localization due to the low transfection levels of the 
construct in HeLa cells.  
 
 
Figure III.8 - A. Intracellular localization of endogenous and transfected Rab11a and Rab11b. A. 
Representative confocal microscopy images of HeLa cells stained with rabbit anti-Rab11a or Rab11b antibodies 
(red), or transfected with Rab11a- or Rab11b-GFP (green). A Z stack is presented, scale bar: 10 µm. B. Co-
localization of Rab11a and Rab11b. B. Representative confocal microscopy images of HeLa cells transfected with 
both Rab11a-GFP (green) and Rab11b-mCherry (red). The channels were splitted (Rab11a-GFP and Rab11b-
mCherry) and then Merged (Merge). A Z stack is presented, Scale bar: 10 µm. Images are representative of three 
or more independent experiments. 
A 
B 
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Figure III.9 - Intracellular localization of Rab11a and FIP1-C, FIP2 or Myosin Va. Representative confocal 
microscopy images of HeLa cells transfected with FIP1-C-GFP, FIP2-GFP or Myo Va-GFP plasmids (green) and 
stained with arabbit anti-Rab11a antibody (red). A Z stack is shown, scale bar: 10 µm. Images are representative 
of two or more independent experiments. 
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Figure III.10 - Intracellular localization of Rab11b and FIP1-C, FIP2 or Myosin Va. Representative confocal 
microscopy images of HeLa cells transfected with FIP1-C-GFP, FIP2-GFP or Myo Va-GFP plasmids (green) and 
stained with a rabbit anti-Rab11b antibody (red). A Z stack is shown, scale bar: 10 µm. Images are representative 
of two or more independent experiments. 
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Finally, we analysed the intracellular localization of the exocyst complex subunits Sec15, Sec8 and 
Exo70. Transfection with Sec15-GFP resulted in the formation of numerous dots dispersed in the 
cytoplasm and small tubulovesicular structures near the perinuclear region (Figure III.11/12). Rab11a 
and Rab11b were found to co-localize strikingly with Sec15-GFP in its different localizations within the 
cell (Figure III.11/12). As observed before, Rab11a or Rab11b changed their localization with the 
overexpression of Sec15. Noteworthy, neither Rab11a nor Rab11b co-localize with Sec8, which has a 
diffuse distribution all over the cell (Figure III.11/12), or Exo70, which is mostly localized at the PM 
(Figure III.11/12). Because the exocyst complex is not always assembled, the different exocyst 
components can have different localizations within the cell. Thus Rab11a and Rab11b might not co-
localize with all the exocyst components at steady-state. 
 
Figure III.11 - Intracellular localization of Rab11a and exocyst subunits Sec15, Sec8 or Exo70. 
Representative confocal microscopy images of HeLa cells transfected with Myo Va-GFP, Sec15-GFP, Sec8-GFP 
or Exo70-GFP plasmids (green) and stained with a rabbit anti-Rab11a antibody (red). A Z stack is shown, scale 
bar: 10 µm. Images are representative of two or more independent experiments. 
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Because we want to study the role of Rab11a/b and its effectors in Ca2+-regulated lysosome 
exocytosis, we also stimulated cells with ionomycin, to investigate if it affects the intracellular localization 
of Rab11a, Rab11b or the effector proteins. However, there were no relevant differences in their 
localization or in the degree of co-localization observed, suggesting that ionomycin stimulation does not 
affect Rab11a/b or Rab11a/b effectors positioning in the cell (data not shown). 
 
 
 
 
 
 
Figure III.12 - Intracellular localization of Rab11b and exocyst subunits Sec15, Sec8 or Exo70.  
Representative confocal microscopy images of HeLa cells transfected with Myo Va-GFP, Sec15-GFP, Sec8-GFP 
or Exo70-GFP plasmids (green) and stained with a rabbit anti-Rab11b antibody (red). A Z stack is shown, scale 
bar: 10 µm. Images are representative of two or more independent experiments. 
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4. Intracellular localization of Rab11a/b and lysosomes in HeLa cells 
 
In order to obtain insights into the molecular mechanism by which Rab11a and Rab11b regulate 
the lysosome exocytosis, we analysed the intracellular localization of Rab11a, Rab11b and lysosomes, 
both at steady-state and after ionomycin stimulation, by confocal immunofluorescence microscopy. 
At steady-state, we observed that both Rab11a and Rab11b accumulate in perinuclear region, but 
are also distributed throughout the cytoplasm in vesicles and near the PM (Figure III.13, A). The 
LE/lysosome marker LAMP1 accumulates in the perinuclear region but also localizes throughout the 
cytoplasm and at the cell tips (Figure III.13, A). In non-stimulated HeLa cells, Rab11a/b and LAMP1 
localize in close proximity in some regions of the cell, especially near the cell tips, but do not co-localize 
(Figure III.13, A). Ionomycin stimulation increases LAMP1 at the cell tips but the co-localization with 
Rab11a and Rab11b remains absent (Figure III.13, B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.13 - Intracellular localization of Rab11 and LAMP1 in HeLa cells. - Representative confocal 
microscopy images of HeLa cells stained with a rabbit anti-Rab11a (red) and a mouse anti-LAMP1 (green) 
antibodies, at steady-state (upper panel) or upon 4 µM ionomycin stimulation (lower panel). A Z stack is shown, 
scale bar: 10 µm. Images are representative of two or more independent experiments. 
A 
B 
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It is possible that Rab11a/b and LE/lysosomes interact transiently at the cell periphery just before 
lysosome fusion with the PM. However, since only a small percentage of lysosomes undergo exocytosis, 
it might not be possible to detect this type of interaction in fixed cells. To detect any transient interaction, 
we used live cell imaging, which allows the observation of intracellular structures in real-time and over 
time and therefore can detect rare and transient events.  
To investigate if Rab11a and Rab11b interact with lysosomes at steady-state and during lysosome 
exocytosis, we transfected HeLa cells with Rab11a- or Rab11b-GFP and tracked LE/lysosomes using 
Lysotracker, which stains acidic compartments. In order to understand the impact of ionomycin 
stimulation in Rab11a/b and lysosome intracellular localization we imaged the cells for a few minutes at 
steady-state and until 10 minutes after ionomycin stimulation because Ca2+-triggered lysosome 
exocytosis occurs very fast. 
Similar to what was observed in fixed cells, at steady-state Rab11a-GFP accumulates at the 
perinuclear region, even though, it is also distributed all over the cell and at the cell tips (Figure III.14, A 
and Supplementary Data Video 1). LE/lysosomes stained with Lysotracker localize near the perinuclear 
region, but they are also found distributed throughout the cytoplasm (Figure III.14, A and Supplementary 
Data Video 1). After stimulation, there is an accumulation of both Rab11a and LE/lysosomes at the cell 
tips, over time (white square; Figure III.14, A and Supplementary Data Video 1/2/3). In fact, when we 
zoomed in a specific region near the cell periphery, it was clear that Rab11a and lysosomes co-localize 
for a few seconds (Figure III.14, A and Supplementary Data Video 4). Nevertheless, the interaction is 
transient because the yellow dots appear and disappear over time (Figure III.14, B and Supplementary 
Data Video 4). These results suggest that ionomycin triggers the interaction of LE/lysosomes with 
Rab11a-positive vesicles. 
Regarding Rab11b, it shows a similar pattern when compared with Rab11a. However, Rab11b-
GFP appeared to be more dispersed throughout the cytoplasm, with less accumulation at the perinuclear 
region (Figure III.15, A and Supplementary Data Video 5/6/7). Similar to what was observed for Rab11a, 
Rab11b-positive vesicles and lysosomes interact transiently at the cell periphery (Figure III.15, B and 
Supplementary Data Video 8), because we detected yellow dots appearing intermittently over time 
(Figure III.15, B and Supplementary Data Video 8). 
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Figure III.14 - Rab11a and lysosomes co-localize transiently at the cell tips upon ionomycin stimulation. A. 
Live cell imaging of HeLa cells transiently transfected with Rab11a-GFP and incubated for 1 hour with Lysotracker 
to stain LE/lysosomes. The cells were imaged for 3 minutes before adding ionomycin (No ionomycin; -90 sec), and 
for 10 minutes (595 sec) after stimulation with 4 µM ionomycin. The channels were split (Rab11a-GFP and 
Lysotracker) and then merged (Merge). The time frames are shown as Z projections of the stacks. B. Zoom of a 
cell tip (white square, A). Over time, lysosomes accumulate at the cell periphery where they transiently interact with 
Rab11a (white arrows, visualized in yellow). Images are representative of two independent experiments.   
A 
B 
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Figura III.15 - Rab11b and lysosomes co-localize transiently at the cell tips upon ionomycin stimulation. A. 
Live cell imaging of HeLa cells transiently transfected with Rab11b-GFP and incubated for 1 hour with Lysotracker 
to stain LE/lysosomes. The cells were imaged for 3 minutes before adding ionomycin (No ionomycin; -90 sec), and 
for 10 minutes (595 sec) after stimulation with 4 µM ionomycin. The channels were split (Rab11b-GFP and 
Lysotracker) and then merged (Merge). The time frames are shown as Z projections of the stacks. B. Zoom of a 
cell tip (white square, A). Over time, lysosomes accumulate at the cell periphery where they interact transiently with 
Rab11b (white arrows, visualized in yellow). Images are representative of two independent experiments.   
B 
A 
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IV. Discussion 
 
The exocytosis of conventional lysosomes is now accepted as an ubiquitous process present in all 
cells. However, the molecular machinery involved in lysosome trafficking to the cell periphery and fusion 
with the PM is not fully understood. This process needs to be tightly regulated and balanced with the 
degradative function of lysosomes. Therefore, the discovery of new regulators of lysosome exocytosis, 
is essential to understand this mechanism an its role in cell physiology and pathology. Our group found 
that Rab11a and Rab11b are required for the regulation of conventional lysosome exocytosis 
(unpublished). However, the molecular mechanism by which these small GTPases regulate Ca2+-
triggered lysosome exocytosis is still not clear. Because Rab11 exerts its function through the interaction 
with effector proteins, that preferentially bind to the active form of the protein, our main aim was to find 
Rab11a/b effector proteins that impair lysosome exocytosis when silenced, to a similar extent to the 
silencing of Rab11a/b. 
In our study, we decided to start by investigating proteins that were already described in the 
literature to interact with Rab11a/b, such as FIPs, Myo Va/b and subunits of the exocyst complex. These 
proteins are known to perform important functions, namely targeting, transport and tethering of Rab11-
positive vesicles.  
To test the involvement of Rab11a/b effector proteins in lysosome exocytosis, we increased the 
intracellular Ca2+ concentration, using the Ca2+ ionophore ionomycin and used two different read-outs 
to investigate the levels of lysosome exocytosis. First we measured the LE/lysosome marker LAMP1 at 
the cell surface and, in a second approach, the release of the lysosomal hydrolytic enzyme β-
hexosaminidase, to confirm that we were detecting the fusion of lysosomes with the PM, rather than LE.  
Among the effector proteins tested, the silencing of the exocyst subunit Sec15 was the only case 
showing a decrease in LAMP1 cell surface expression levels, similar to what was observed upon 
silencing of Rab11a/b. This suggests that Sec15 acts together with Rab11a/b in the regulation of 
lysosome exocytosis. As mentioned before, we also analysed the release of the lysosomal enzyme β-
hexosaminidase. In this case, the silencing of Sec15 does not induce a significant decrease in the 
percentage of released enzyme when compared with siControl. However, there is a significant decrease 
when compared with non-transfected and mock-transfected cells, suggesting that the siControl used 
impairs the release of β-hexosaminidase non-specifically. Therefore, this could be masking the real 
effect of the silencing of Sec15 in β-hexosaminidase release, that seems to decrease the secretion of 
the lysosomal enzyme, in agreement to what is observed for LAMP1 surface expression. To confirm this 
hypothesis, further assays have to be performed using a different siControl. Although the results for 
Sec15 were not conclusive in the case of β-hexosaminidase release, it was the most promising target 
identified to be required for lysosome exocytosis, together with Rab11a/b. Surprisingly, the silencing of 
the other subunits of the exocyst complex, do not affect neither LAMP1 expression nor the release of β-
hexosaminidase, suggesting that the exocyst complex is not involved in lysosome exocytosis. 
Interestingly, the exocyst complex was found to be involved, togheter with Rab11 in the exocytosis of 
RE (Takahashi et al., 2012). Our results suggest that in the case of Rab11-regulated lysosome 
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exocytosis, Sec15 acts independently of the exocyst complex. Moreover, it is known that Sec15 binds 
directly to Rab11 (Zhang et al., 2004) and is the first subunit that interacts with Rab11, during the 
assembly of the complex (Welz et al., 2014). We confirmed that the subunits tested interact with Rab11 
in HeLa cells, but we observed that when we overexpress these subunits, Rab11 is recruited to where 
Sec15 localizes, in contrast to what we observed for Sec8 and Exo70, in which the overexpression does 
not affect the localization of Rab11. This reinforces the evidence that Rab11 and Sec15 interact directly, 
without requiring the assembly of the rest of the complex. Interestingly, it has been suggested that Sec15 
also binds directly to the Sec10 subunit, forming a sub-complex with unknown functions (Zhang et al., 
2004; Heider and Munson, 2012). Thus, it would be interesting to silence Sec10, and confirm if it is also 
involved in lysosome exocytosis. 
FIPs are known to be involved in Rab11-mediated endocytic recycling (Horgan and McCaffrey, 
2009; Kelly et al., 2012), and by mediating the binding of Rab11 to Myo Va/b (Schafer et al., 2013). 
Surprisingly, the silencing of the FIP1-C or FIP2 increases both LAMP1 cell surface expression and the 
release of β-hexosaminidase. These results indicate that in the absence of FIP1-C or FIP2, there is an 
increase in lysosome exocytosis, thus suggesting that these FIPs are negative regulators of this 
process. Because, FIPs mediate the binding of Rab11 to motor proteins that regulate vesicle positioning, 
we expected that their silencing would lead to the impairment of the correct localization of Rab11-
positive vesicles, thus decreasing lysosome exocytosis. Previous studies have already suggested that 
in the absence of FIP2, Rab11a-positive vesicles lose the capacity to bind Myo Vb and move faster 
within the cell (Schafer et al., 2013). Therefore, in the absence of FIP2, there could be an increase in 
the motility of Rab11-positive vesicles, leading to a higher dispersion and accumulation at the cell 
periphery, and increasing the probability of their interaction with lysosomes. Curiously, it has also been 
suggested that the depletion of FIP1 enhances adiponectin release (Carson et al., 2013), similar to what 
we observed in lysosome exocytosis. We also observed that FIP2 interacts with Rab11 and that the 
overexpression of FIP1-C or FIP2, mislocalizes Rab11 to where the FIPs are localized. Thus, the 
increase in lysosome exocytosis upon FIP1-C or FIP2 silencing suggests that when the FIPs are 
present, Rab11 binds to them and performs its functions in endocytic recycling traffic. However, when 
FIP1-C or FIP2 are not present, Rab11 is more available to interact with other effector proteins, such as 
Sec15, which is required for the regulation of lysosome exocytosis. 
Myosin V family members are known to be involved in the transport of vesicles along the actin 
cytoskeleton, including Rab11-positive vesicles (Lapierre et al., 2001). Myo Vb is linked to Rab11-
positive vesicles by FIP2, regulating their motility and positioning (Schafer et al., 2013), whereas Myo 
Va was found to regulate the movement of melanosomes along the cortical actin network (Strom et al., 
2002). Due to their role in the transport of vesicles, at the cell periphery, we expected that Myo Va/Vb 
could be important for the transport of Rab11-positive vesicles and to their correct positioning close to 
the PM. In fact, when we overexpressed Myo Va we observed that it localizes at the cell periphery and 
recruits Rab11a/b to the cell tips. Thus, we speculate that Myo Va/b could increase the probability of an 
interaction between Rab11-positive vesicles and lysosomes at the cell periphery. And if so we expected 
a decrease in lysosome exocytosis in the absence of Myo Va/b expression. However, we observed that 
the silencing of Myo Vb, which is well described to interact with Rab11a/b, increases LAMP1 cell surface 
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expression levels, while Myo Va does not cause significant differences in any of the read-outs. In view 
of these results, the increase in LAMP1 cell surface expression upon Myo Vb silencing, could be 
explained by the fact that Myo Vb interacts with FIP2, that when silenced also increases lysosome 
exocytosis. 
Although, the mechanism by which Rab11 regulates Ca2+-triggered lysosome exocytosis is not 
understood, we hypothesized that, due to the similarities between lysosomes and LROs, it is likely that 
Rab11a/b have similar functions in the regulated exocytosis of lysosomes. Our group showed that 
Rab11b has a role in the regulated exocytosis of melanosomes, presumably by inducing the remodeling 
of the membrane of melanosomes priming them for secretion (Tarafder et al., 2014). Moreover, the 
studies in CTLs, suggest the existence of a transient interaction between immature lytic granule vesicles 
and Rab11-positive vesicles that is essential to prime lytic granules for the late steps of exocytosis (Sluijs 
et al., 2013). Thus, to gain new insights about the spatial and temporal intersection of the endocytic 
recycling pathway with lysosomes, we investigated the intracellular localization of Rab11a and Rab11b 
and LE/lysosomes at steady-state or after ionomycin stimulation. 
By confocal microscopy, we observed that the stimulation with ionomycin increases LE/lysosomes 
accumulation near the PM, particularly at the cell tips. This was expected, since we observed an 
increase in LAMP1 at the cell surface by flow cytometry under these conditions. However, Rab11a and 
Rab11b localization is not significantly affected upon ionomycin stimulation. Interestingly, when cells are 
stimulated we observed that LAMP1 localizes in close proximity to Rab11a/b-positive vesicles at the cell 
periphery. Thus, we hypothesize that Rab11a/b-positive vesicles and lysosomes interact transiently at 
the cell tips, which could explain why it is not possible to observe these events in fixed cells. Therefore, 
we used live cell imaging to search for possible transient interactions between Rab11a/Rab11b and 
LE/lysosomes. At steady-state, Rab11a/b accumulates near the perinuclear region but is also found 
dispersed all over the cell, including at the cell periphery. LE/lysosomes tend to accumulate at 
perinuclear region, although they are also distributed throughout the cytoplasm. Upon ionomycin 
stimulation, we observed that LE/lysosomes accumulate at the cell periphery where they transiently co-
localize with Rab11a- and Rab11b-positive vesicles. This suggests that Rab11a/b-positive vesicles 
interact transiently with LE/lysosomes at the cell periphery, just before their fusion with the PM. However, 
the interactions between Rab11-positive vesicles and lysosomes are difficult to observe, since these 
are rare events that are restricted to a specific localization. Importantly, it is known that only a small 
percentage of the total pool of lysosomes are able to undergo exocytosis, namely those that have a 
more peripheral localization (Jaiswal et al., 2002), which are also less acidic (Johnson et al., 2016) and 
therefore more prone to fuse with the plasma membrane. Our observations in live cells confirm that only 
peripheral lysosomes undergo Ca2+-triggered exocytosis and that Rab11 could play a role in the late 
steps of lysosome exocytosis, probably by delivering cargo such as SNAREs, necessary for the 
tethering and fusion of lysosomes with the PM. 
The work performed during this thesis resulted in important observations to characterize the 
molecular processes by which Rab11a/b regulates lysosome exocytosis. Silencing of the exocyst 
subunit Sec15 was found to impair lysosome exocytosis. The co-IP of Rab11a/b with Sec15 and the 
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striking co-localization of overexpressed Sec15 with Rab11a/b, suggests that Sec15 interacts with 
Rab11a/b in HeLa cells. However, Sec15 and Rab11a/b might act independently of the exocyst 
complex, since in the absence of the others subunits tested, we could not observe significant differences 
in lysosome exocytosis. Further studies should focus on elucidating the role of Sec15 in Rab11a/b-
mediated regulation of lysosome exocytosis. 
The observation that Rab11a/b-positive vesicles interact transiently with lysosomes at the cell 
periphery is important to understand the role of Rab11a/b in this pathway. In melanosomes and lytic 
granules, the interaction between Rab11-positive vesicles and LROs serves to prime them to undergo 
exocytosis. Therefore, we can hypothesize that Rab11a/b-Sec15 interaction is important to position 
Rab11a/b-positive vesicles and promote the interaction with lysosomes. Another possibility is that Sec15 
acts as an adaptor protein in the interaction of Rab11a/b with other proteins. However, more studies 
have to be done to elucidate these questions. 
The regulated exocytosis of lysosomes has been described as an important mechanism in several 
essential functions. The accumulation of undigested material in lysosomes, characteristic of LSDs, is 
usually related to deficiencies in the activity of lysosomal hydrolytic enzymes. However, impairment in 
lysosome exocytosis and therefore decreased secretion of the lysosomal content could also explain the 
accumulation of undigested material in the cells. Thus, the stimulation of lysosome exocytosis could be 
considered as possibility for the treatment of these diseases. Moreover, the increasing evidence that 
lysosomes are the major vesicles involved in PM repair, reinforce the importance of regulated exocytosis 
in cell survival. Thus, impairment in the exocytosis of lysosomes, might compromise cell responses to 
stress, damage or invasion by pathogens, leading to disease. Therefore, the study of the molecular 
machinery that regulates this process is of major importance.  
In the future, we aim to unveil the molecular mechanism by which Rab11a/b and Sec15 regulate 
lysosome exocytosis and shed light on the molecular mechanisms of diseases where lysosomes 
exocytosis is compromised. 
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